<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>C. elegans Proteostasis Network - Comprehensive Pathway Integration - AI Gene Review Projects</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-primary: #3498db;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1200px;
            margin: 0 auto;
        }

        .breadcrumb {
            margin-bottom: 1.5rem;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .breadcrumb a {
            color: var(--color-primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        h2 {
            font-size: 1.75rem;
            font-weight: 600;
            margin-top: 2rem;
            margin-bottom: 1rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        h3 {
            font-size: 1.25rem;
            font-weight: 600;
            margin-top: 1.5rem;
            margin-bottom: 0.75rem;
            color: #374151;
        }

        h4 {
            font-size: 1rem;
            font-weight: 600;
            margin-top: 1.25rem;
            margin-bottom: 0.5rem;
            color: #4b5563;
        }

        p {
            margin-bottom: 1rem;
        }

        a {
            color: var(--color-primary);
            text-decoration: none;
        }

        a:hover {
            text-decoration: underline;
        }

        /* Gene symbol links */
        .content a[href*="/genes/"] {
            background-color: #dbeafe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-weight: 500;
        }

        .content a[href*="/genes/"]:hover {
            background-color: #bfdbfe;
        }

        ul, ol {
            margin-bottom: 1rem;
            padding-left: 2rem;
        }

        li {
            margin-bottom: 0.25rem;
        }

        code {
            background: #f4f4f4;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-family: 'SFMono-Regular', Consolas, 'Liberation Mono', Menlo, monospace;
            font-size: 0.875em;
        }

        pre {
            background: #1f2937;
            color: #f9fafb;
            padding: 1rem;
            border-radius: 0.5rem;
            overflow-x: auto;
            margin-bottom: 1rem;
        }

        pre code {
            background: none;
            padding: 0;
            color: inherit;
        }

        blockquote {
            border-left: 4px solid var(--color-primary);
            margin-left: 0;
            padding-left: 1.5rem;
            color: #4b5563;
            font-style: italic;
            margin-bottom: 1rem;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 1.5rem 0;
        }

        th, td {
            border: 1px solid var(--border-color);
            padding: 0.75rem;
            text-align: left;
        }

        th {
            background-color: var(--bg-light);
            font-weight: 600;
            color: var(--text-muted);
            text-transform: uppercase;
            font-size: 0.75rem;
            letter-spacing: 0.05em;
        }

        tr:nth-child(even) {
            background-color: #f9fafb;
        }

        tr:hover {
            background-color: #f3f4f6;
        }

        /* Mermaid diagrams */
        .mermaid {
            text-align: center;
            margin: 2rem 0;
            background: white;
            padding: 1.5rem;
            border-radius: 0.5rem;
            border: 1px solid var(--border-color);
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        /* Warnings section */
        .warnings {
            background-color: #fef3c7;
            border: 1px solid #fde68a;
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 2rem;
        }

        .warnings h3 {
            color: #92400e;
            margin-top: 0;
            margin-bottom: 0.5rem;
            font-size: 1rem;
        }

        .warnings ul {
            margin-bottom: 0;
            color: #78350f;
        }

        /* Task lists (checkboxes) */
        li input[type="checkbox"] {
            margin-right: 0.5rem;
        }

        /* Status badges */
        .badge {
            display: inline-block;
            padding: 0.25rem 0.625rem;
            border-radius: 9999px;
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
        }

        .badge-success {
            background-color: #d1fae5;
            color: #065f46;
        }

        .badge-warning {
            background-color: #fef3c7;
            color: #92400e;
        }

        .badge-info {
            background-color: #dbeafe;
            color: #1e40af;
        }

        /* Content wrapper */
        .content {
            margin-bottom: 2rem;
        }

        /* Footer */
        footer {
            margin-top: 3rem;
            padding-top: 1.5rem;
            border-top: 1px solid var(--border-color);
            color: var(--text-muted);
            font-size: 0.875rem;
            text-align: center;
        }

        footer small {
            display: block;
        }
    </style>
    <!-- Mermaid.js for diagram rendering -->
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            themeVariables: {
                primaryColor: '#3498db',
                primaryTextColor: '#fff',
                primaryBorderColor: '#2c3e50',
                lineColor: '#333',
                secondaryColor: '#ecf0f1',
                tertiaryColor: '#f39c12'
            },
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <nav class="breadcrumb">
        <a href="../index.html">Home</a> &raquo;
        <a href="index.html">Projects</a> &raquo;
        C. elegans Proteostasis Network - Comprehensive Pathway Integration
    </nav>

    <header class="header">
        <h1>C. elegans Proteostasis Network - Comprehensive Pathway Integration</h1>
        
    </header>

    
    <div class="warnings">
        <h3>Warnings (4)</h3>
        <ul>
            
            <li>Ambiguous symbol &#39;hsf-1&#39; found in species: CAEEL, worm. Add &#39;species: [CAEEL]&#39; to frontmatter to resolve.</li>
            
            <li>Ambiguous symbol &#39;ATG7&#39; found in species: human, yeast. Add &#39;species: [human]&#39; to frontmatter to resolve.</li>
            
            <li>Ambiguous symbol &#39;daf-16&#39; found in species: CAEEL, worm. Add &#39;species: [CAEEL]&#39; to frontmatter to resolve.</li>
            
            <li>Ambiguous symbol &#39;cdc-48&#39; found in species: CAEEL, worm. Add &#39;species: [CAEEL]&#39; to frontmatter to resolve.</li>
            
        </ul>
    </div>
    

    <div class="content">
        <h1 id="c-elegans-proteostasis-network-comprehensive-pathway-integration">C. elegans Proteostasis Network - Comprehensive Pathway Integration</h1>
<h2 id="project-overview">Project Overview</h2>
<p>This document integrates the curation of <strong>18 C. elegans proteostasis genes</strong> (868 total GO annotations) into a unified biological pathway with evolutionary and clinical context. The proteostasis network maintains cellular protein homeostasis through heat shock response (HSR), ubiquitin-proteasome system (UPS), autophagy, and longevity signaling pathways that decline with age.</p>
<p><strong>Gene Review Coverage</strong>:<br />
- Priority 1 (HSR): 6 genes, 234 annotations - COMPLETE<br />
- Priority 2 (Degradation): 6 genes, 213 annotations - COMPLETE<br />
- Priority 3 (Longevity Link): 6 genes, 421 annotations - COMPLETE</p>
<hr />
<h2 id="part-1-the-heat-shock-response-master-regulation-of-proteostasis">Part 1: The Heat Shock Response - Master Regulation of Proteostasis</h2>
<h3 id="11-hsf-1-master-transcriptional-regulator-68-annotations">1.1 HSF-1: Master Transcriptional Regulator (68 annotations)</h3>
<p><strong>UniProt</strong>: G5EFQ9 | <strong>Human Ortholog</strong>: HSF1 | <strong>Key Function</strong>: Heat Shock Factor 1</p>
<h4 id="core-molecular-functions-accept-43-annotations">Core Molecular Functions (ACCEPT - 43 annotations)</h4>
<ul>
<li><strong>DNA binding</strong>: Sequence-specific binding to Heat Shock Elements (HSE) in gene promoters</li>
<li><strong>Transcriptional activation</strong>: Positive regulation of heat shock protein gene expression</li>
<li><strong>Protein homodimerization</strong>: Forms trimeric complexes for DNA binding</li>
<li><strong>Proteostasis response</strong>: Master regulator of protein quality control network</li>
</ul>
<h4 id="biological-context">Biological Context</h4>
<p>HSF-1 is the apex transcriptional regulator of the proteostasis network. Under normal conditions, HSF-1 remains predominantly cytoplasmic and inactive. Upon heat shock or proteotoxic stress:</p>
<ol>
<li><strong>Activation mechanism</strong>: Protein misfolding triggers HSF-1 hyperphosphorylation and trimerization</li>
<li><strong>Localization</strong>: Translocates to nuclear stress granules (distinct subnuclear structures)</li>
<li><strong>Target genes</strong>: Activates ~100 genes encoding chaperones (<a href="../../genes/worm/hsp-1/hsp-1-ai-review.html">hsp-1</a>, <a href="../../genes/worm/hsp-4/hsp-4-ai-review.html">hsp-4</a>, <a href="../../genes/worm/hsp-16.2/hsp-16.2-ai-review.html">hsp-16.2</a>, <a href="../../genes/worm/hsp-90/hsp-90-ai-review.html">hsp-90</a>, <a href="../../genes/worm/daf-21/daf-21-ai-review.html">daf-21</a>), co-chaperones, and disaggregases</li>
<li><strong>Lifespan effects</strong>: IIS pathway mutations (<a href="../../genes/worm/daf-2/daf-2-ai-review.html">daf-2</a>(-)) extend HSF-1 activity and longevity</li>
</ol>
<h4 id="non-core-functions-keep_as_non_core-16-annotations">Non-Core Functions (KEEP_AS_NON_CORE - 16 annotations)</h4>
<ul>
<li>Dauer formation regulation (indirect, via ascaroside pheromone biosynthesis)</li>
<li>Developmental processes (E2F-dependent, independent of heat stress)</li>
<li>Defense responses (mediated through HSP90/DAF-21 client stabilization)</li>
<li>Metabolism regulation (affects lipid and carbohydrate pathways)</li>
</ul>
<h4 id="key-evidence">Key Evidence</h4>
<ul>
<li><strong>IDA evidence</strong>: HSF-1::GFP imaging shows constitutive nuclear localization (PMID:23107491)</li>
<li><strong>IMP evidence</strong>: hsf-1 deletion blocks heat shock protein induction (PMID:26212459)</li>
<li><strong>IPI evidence</strong>: Direct protein-protein interactions with co-factors and DNA</li>
</ul>
<p><strong>Clinical Relevance</strong>: HSF1 dysregulation is implicated in cancer progression (tumor-promoting), neurodegeneration (protective), and aging (capacity declines with age).</p>
<hr />
<h3 id="12-hsp-1-constitutive-hsp70-chaperone-26-annotations">1.2 HSP-1: Constitutive HSP70 Chaperone (26 annotations)</h3>
<p><strong>UniProt</strong>: P09446 | <strong>Human Ortholog</strong>: HSPA8 | <strong>Key Function</strong>: Cytosolic HSP70</p>
<h4 id="core-molecular-functions-accept-14-annotations">Core Molecular Functions (ACCEPT - 14 annotations)</h4>
<ul>
<li><strong>ATP-dependent protein folding</strong>: Core chaperone mechanism</li>
<li><strong>Unfolded protein binding</strong>: Recognition of exposed hydrophobic sequences</li>
<li><strong>ATP hydrolysis activity</strong>: Energy-dependent conformational changes</li>
<li><strong>Co-chaperone binding</strong>: Interactions with STI-1, UNC-45, UNC-23</li>
</ul>
<h4 id="mechanistic-role">Mechanistic Role</h4>
<p>HSP-1 is the primary constitutive (basal) cytosolic HSP70 in C. elegans. Unlike inducible HSP-70 (heat shock-responsive), HSP-1 is continuously expressed and available for immediate chaperone functions. Works through:</p>
<ol>
<li><strong>ATP hydrolysis cycle</strong>: Uses ATP energy to bind misfolded proteins</li>
<li><strong>Co-chaperone cooperation</strong>: STI-1 (Hop ortholog) works with HSP-1 to deliver substrates to HSP-90</li>
<li><strong>Protein refolding</strong>: ATP-dependent unfolding and refolding of partially folded proteins</li>
<li><strong>Disaggregation</strong>: With HSP-110 and AAA+ ATPases, dissolves small aggregates</li>
</ol>
<h4 id="cellular-localizations-accept">Cellular Localizations (ACCEPT)</h4>
<ul>
<li>Cytoplasm (primary)</li>
<li>Nuclear (stress-inducible)</li>
<li>Plasma membrane (endocytic trafficking)</li>
<li>Mitochondrial surface (quality control)</li>
</ul>
<h4 id="non-core-functions-keep_as_non_core-2-annotations">Non-Core Functions (KEEP_AS_NON_CORE - 2 annotations)</h4>
<ul>
<li>Lifespan determination (indirect proteostasis effect)</li>
<li>Endosomal trafficking (marginal role)</li>
</ul>
<h4 id="key-evidence_1">Key Evidence</h4>
<ul>
<li><strong>IDA evidence</strong>: Multiple localizations confirmed by fluorescence microscopy (PMID:25053410)</li>
<li><strong>IEA evidence</strong>: ATP-dependent folding mechanism confirmed through domain analysis</li>
<li><strong>IPI evidence</strong>: Direct co-chaperone interactions from biochemical assays (PMID:19467242)</li>
</ul>
<p><strong>Clinical Relevance</strong>: HSPA8 mutations cause Charcot-Marie-Tooth disease (hereditary neuropathy); HSP70s are therapeutic targets in Alzheimer's and Parkinson's disease.</p>
<hr />
<h3 id="13-hsp-162-small-heat-shock-protein-11-annotations">1.3 HSP-16.2: Small Heat Shock Protein (11 annotations)</h3>
<p><strong>UniProt</strong>: P06582 | <strong>Human Ortholog</strong>: HSPB1 | <strong>Key Function</strong>: Alpha-crystallin family sHSP</p>
<h4 id="core-molecular-functions-accept-8-annotations">Core Molecular Functions (ACCEPT - 8 annotations)</h4>
<ul>
<li><strong>Unfolded protein binding</strong>: ATP-independent "holdase" activity</li>
<li><strong>Protein aggregation prevention</strong>: Prevents aggregation of misfolded proteins</li>
<li><strong>Heat shock response</strong>: Stress-inducible expression under HSF-1 control</li>
</ul>
<h4 id="mechanistic-role-atp-independent">Mechanistic Role (ATP-Independent)</h4>
<p>Unlike HSP70s and HSP90s that use ATP hydrolysis, small HSPs (sHSPs) are ATP-independent chaperones that:</p>
<ol>
<li><strong>Holdase function</strong>: Binds unfolded proteins and prevents aggregation</li>
<li><strong>Aggregate clearance</strong>: Shuttles aggregates to other chaperones or proteasome</li>
<li><strong>Thermotolerance</strong>: Provides thermal protection by buffering protein unfolding</li>
</ol>
<p>Structure: ~16 kDa monomers form dynamic oligomers with characteristic alpha-crystallin domain (characteristic of alpha-crystallin family).</p>
<h4 id="proposed-new-annotation">Proposed New Annotation</h4>
<ul>
<li><strong>GO:0044183</strong>: Protein folding chaperone (replaces incorrect "protein refolding")</li>
</ul>
<h4 id="key-curation-decision">Key Curation Decision</h4>
<ul>
<li><strong>REMOVE</strong>: GO:0042026 (protein refolding) - mechanistically incorrect; sHSPs are holdases, not refolding enzymes</li>
<li>This distinction is critical: sHSPs prevent aggregation but don't directly refold proteins (that's HSP70/HSP90 role)</li>
</ul>
<h4 id="key-evidence_2">Key Evidence</h4>
<ul>
<li><strong>IEP evidence</strong>: Heat shock-inducible expression from transgenic reporters (PMID:1550963)</li>
<li><strong>ISS evidence</strong>: Conserved alpha-crystallin domain from sequence alignment (PMID:3017958)</li>
</ul>
<p><strong>Clinical Relevance</strong>: HSPB1 mutations cause Charcot-Marie-Tooth disease; sHSPs are involved in neurodegenerative disease protection.</p>
<hr />
<h3 id="14-hsp-90-molecular-chaperone-with-signaling-roles-52-annotations">1.4 HSP-90: Molecular Chaperone with Signaling Roles (52 annotations)</h3>
<p><strong>UniProt</strong>: Q18688 | <strong>Human Ortholog</strong>: HSP90AA1 | <strong>Key Function</strong>: Conserved chaperone for signaling proteins</p>
<h4 id="core-molecular-functions-accept-28-annotations">Core Molecular Functions (ACCEPT - 28 annotations)</h4>
<ul>
<li><strong>ATP hydrolysis activity</strong>: Energy-dependent chaperone mechanism</li>
<li><strong>ATP-dependent protein folding</strong>: Specialized for signal transduction proteins</li>
<li><strong>Unfolded protein binding</strong>: Recognition and stabilization of client proteins</li>
<li><strong>Homodimerization</strong>: Essential for catalytic activity</li>
<li><strong>Protein stabilization</strong>: Prevents ubiquitin-dependent degradation of clients</li>
</ul>
<h4 id="distinctive-features">Distinctive Features</h4>
<p>HSP90 has specialized roles distinct from general-purpose chaperones:</p>
<ol>
<li><strong>Client selectivity</strong>: Preferentially stabilizes kinases, transcription factors, steroid receptors</li>
<li><strong>Co-chaperone dependence</strong>: Requires CDC-37 and other co-chaperones for substrate specificity</li>
<li><strong>Signaling involvement</strong>: Critical for signal transduction in cell division, differentiation</li>
<li><strong>Cryptic genetic variation buffering</strong>: Proposed to buffer genetic variation in development</li>
</ol>
<h4 id="hsp90-clients-in-c-elegans">HSP90 Clients in C. elegans</h4>
<ul>
<li><strong>DAF-1</strong>: TGF-beta receptor (PMID:14992718)</li>
<li><strong>UNC-45</strong>: Myosin chaperone co-factor (PMID:11809970)</li>
<li><strong>STI-1</strong>: Co-chaperone recruitment (PMID:19467242)</li>
<li><strong>PPH-5</strong>: Protein phosphatase 5 (PMID:1990634)</li>
<li><strong>LET-756</strong>: FGF ligand (PMID:16672054)</li>
</ul>
<h4 id="non-core-functions-keep_as_non_core-9-annotations">Non-Core Functions (KEEP_AS_NON_CORE - 9 annotations)</h4>
<ul>
<li>Chemotaxis and sensory signaling (mediated through DAF-1 receptor stabilization)</li>
<li>Defense response (immune genes activated downstream of stabilized transcription factors)</li>
<li>Dauer formation (developmental consequence)</li>
<li>Lifespan determination (proteostasis consequence)</li>
</ul>
<h4 id="key-curation-decision_1">Key Curation Decision</h4>
<ul>
<li><strong>MODIFY</strong>: 10 generic "protein binding" annotations → GO:0051879 "Hsp90 protein binding" (specific, mechanistic)</li>
</ul>
<h4 id="key-evidence_3">Key Evidence</h4>
<ul>
<li><strong>IBA evidence</strong>: Phylogenetic conservation across eukaryotes with experimental validation</li>
<li><strong>IMP evidence</strong>: Genetic interaction studies show essential role in multiple pathways</li>
<li><strong>IPI evidence</strong>: Biochemical identification of client proteins</li>
</ul>
<p><strong>Clinical Relevance</strong>: HSP90 inhibitors are being developed as cancer therapeutics; HSP90 dysfunction implicated in neurodegeneration.</p>
<hr />
<h3 id="15-daf-21-second-hsp90-paralog-with-specialized-functions-52-annotations">1.5 DAF-21: Second HSP90 Paralog with Specialized Functions (52 annotations)</h3>
<p><strong>UniProt</strong>: P41887 | <strong>Human Ortholog</strong>: HSP90AB1 | <strong>Key Function</strong>: Cytoplasmic HSP90</p>
<h4 id="specialized-role-distinct-from-hsp-90">Specialized Role Distinct from HSP-90</h4>
<p>C. elegans has two HSP90 genes (<a href="../../genes/worm/hsp-90/hsp-90-ai-review.html">hsp-90</a> and <a href="../../genes/worm/daf-21/daf-21-ai-review.html">daf-21</a>) with:</p>
<ol>
<li><strong>Overlapping general chaperone functions</strong>: Both can stabilize general client proteins</li>
<li><strong>Distinct developmental functions</strong>: DAF-21 has specific role in dauer formation</li>
<li><strong>Tissue-specific expression</strong>: DAF-21 particularly important in neurons and sensory neurons</li>
</ol>
<h4 id="core-molecular-functions-accept-21-annotations">Core Molecular Functions (ACCEPT - 21 annotations)</h4>
<ul>
<li><strong>ATP hydrolysis activity</strong>: Energy-dependent chaperone</li>
<li><strong>Protein stabilization</strong>: Client protein stabilization</li>
<li><strong>Heat shock response</strong>: HSF-1 inducible</li>
<li><strong>Complex membership</strong>: Part of HSP90-containing molecular machines</li>
</ul>
<h4 id="developmental-role-dauer-formation">Developmental Role: Dauer Formation</h4>
<p>DAF-21 specifically regulates dauer formation through:</p>
<ol>
<li><strong>Dauer decision pathway</strong>: Controls sensory neuron function (OSM-9 channel stabilization)</li>
<li><strong>Pheromone sensing</strong>: Stabilizes GPCR signaling components</li>
<li><strong>Nuclear export</strong>: YAP-1 (DAF-16-like TF) regulation via nuclear protein export</li>
</ol>
<h4 id="non-core-functions-keep_as_non_core-9-annotations_1">Non-Core Functions (KEEP_AS_NON_CORE - 9 annotations)</h4>
<ul>
<li>Chemotaxis and sensory transduction (cell-nonautonomous)</li>
<li>Defense response to bacteria (mediated through transcription factor stabilization)</li>
<li>Lifespan determination (longevity extension via HSF-1 activation)</li>
</ul>
<h4 id="key-curation-decision_2">Key Curation Decision</h4>
<ul>
<li><strong>MODIFY</strong>: 8 generic "protein binding" → GO:0051879 "Hsp90 protein binding"</li>
</ul>
<p><strong>Clinical Relevance</strong>: HSP90AB1 is implicated in cancer; potential target for neurodegenerative disease therapy.</p>
<hr />
<h3 id="16-hsp-4-er-resident-bipgrp78-chaperone-25-annotations">1.6 HSP-4: ER-Resident BiP/GRP78 Chaperone (25 annotations)</h3>
<p><strong>UniProt</strong>: Q966C6 | <strong>Human Ortholog</strong>: HSPA5 | <strong>Key Function</strong>: ER lumen HSP70</p>
<h4 id="unique-er-specialization">Unique ER Specialization</h4>
<p>HSP-4 is the sole ER-resident HSP70 ortholog in C. elegans (mammalian BiP/GRP78), with strict ER luminal localization:</p>
<h4 id="core-molecular-functions-accept-17-annotations">Core Molecular Functions (ACCEPT - 17 annotations)</h4>
<ul>
<li><strong>ATP hydrolysis activity</strong>: ER-specific chaperone mechanism</li>
<li><strong>Protein folding</strong>: ER protein folding and maturation</li>
<li><strong>Unfolded protein binding</strong>: Recognition of misfolded ER proteins</li>
<li><strong>Protein refolding</strong>: ATP-dependent unfolding/refolding in ER lumen</li>
<li><strong>ERAD pathway participation</strong>: Extracts misfolded proteins for proteasomal degradation</li>
<li><strong>ER chaperone complex formation</strong>: Works with other ER chaperones</li>
</ul>
<h4 id="upr-er-marker-gene">UPR-ER Marker Gene</h4>
<p>HSP-4::GFP is the canonical reporter for ER unfolded protein response (UPR-ER) activation in C. elegans. Expression increases upon:</p>
<ol>
<li><strong>ER stress</strong>: Tunicamycin, DTT, thapsigargin</li>
<li><strong>ER protein misfolding</strong>: Excess misfolded proteins in ER lumen</li>
<li><strong>Redox imbalance</strong>: Disrupted disulfide bond formation</li>
</ol>
<h4 id="upr-er-signaling">UPR-ER Signaling</h4>
<p>HSP-4 induction occurs through:<br />
- <strong>IRE-1/XBP-1 branch</strong>: ER kinase/RNase IRE-1 splices XBP-1 mRNA<br />
- <strong>PEK-1/ATF-4 branch</strong>: PERK kinase phosphorylates eIF2α<br />
- <strong>ATF-6 branch</strong>: Proteolytic activation of ATF-6</p>
<h4 id="non-core-functions-keep_as_non_core-2-annotations_1">Non-Core Functions (KEEP_AS_NON_CORE - 2 annotations)</h4>
<ul>
<li>Nucleus localization (phylogenetic artifact; functional role unclear)</li>
<li>Cytoplasm localization (marginal)</li>
</ul>
<h4 id="mark-as-over-annotated-mark_as_over_annotated-1-annotation">Mark as Over-Annotated (MARK_AS_OVER_ANNOTATED - 1 annotation)</h4>
<ul>
<li>GO:0016020 (membrane) - too general; should be "ER membrane" or "ER lumen"</li>
</ul>
<h4 id="key-evidence_4">Key Evidence</h4>
<ul>
<li><strong>IEP evidence</strong>: Multiple experimental studies of stress-inducible <a href="../../genes/worm/hsp-4/hsp-4-ai-review.html">hsp-4</a> expression (PMID:11779465, PMID:18216284)</li>
<li><strong>HEP evidence</strong>: Historic experimental evidence from immunoblots (PMID:12186849)</li>
<li><strong>IDA evidence</strong>: Rough ER localization from EM studies (PMID:26052671)</li>
</ul>
<p><strong>Clinical Relevance</strong>: BiP/GRP78 dysregulation implicated in diabetes, neurodegenerative disease, cancer (tumor-promoting); potential therapeutic target.</p>
<hr />
<h2 id="part-2-protein-degradation-systems">Part 2: Protein Degradation Systems</h2>
<h3 id="21-cdc-48-aaa-atpase-extracting-proteins-for-degradation-50-annotations">2.1 CDC-48: AAA+ ATPase Extracting Proteins for Degradation (50 annotations)</h3>
<p><strong>UniProt</strong>: <a href="../../genes/worm/P54811/P54811-ai-review.html">P54811</a> | <strong>Human Ortholog</strong>: VCP/p97 | <strong>Key Function</strong>: AAA+ protein unfoldase</p>
<h4 id="plurifunctional-machine">Plurifunctional Machine</h4>
<p>CDC-48 (C. elegans VCP/p97) is a hexameric AAA+ ATPase with pleiotropic cellular functions:</p>
<ol>
<li><strong>Primary function</strong>: Protein unfolding and extraction from protein complexes</li>
<li><strong>ERAD substrate delivery</strong>: Extracts ubiquitinated proteins from ER membrane for proteasomal degradation</li>
<li><strong>Autophagosome maturation</strong>: AAA+ ATPase activity promotes autophagosome-lysosome fusion</li>
<li><strong>DNA replication licensing</strong>: Removes MCM proteins from chromatin post-replication</li>
</ol>
<h4 id="erad-pathway-role">ERAD Pathway Role</h4>
<p>CDC-48 works with adapter proteins (UFD-1/NPL-4, UBXN proteins) to:</p>
<ol>
<li><strong>Substrate recognition</strong>: Binds polyubiquitinated misfolded ER proteins</li>
<li><strong>Membrane extraction</strong>: Uses AAA+ ATPase power to extract from ER lipid bilayer</li>
<li><strong>Substrate transfer</strong>: Transfers to proteasome for 26S-mediated degradation</li>
<li><strong>Complex disassembly</strong>: Also disassembles protein complexes (e.g., replication machinery)</li>
</ol>
<h4 id="core-molecular-functions-accept-29-annotations">Core Molecular Functions (ACCEPT - 29 annotations)</h4>
<ul>
<li><strong>ATP hydrolysis activity</strong>: Energy source for protein unfolding</li>
<li><strong>Polyubiquitin binding</strong>: Recognizes K63-linked polyubiquitin chains</li>
<li><strong>Proteasome-mediated protein catabolism</strong>: Core ERAD activity</li>
<li><strong>Retrograde ER-to-cytosol transport</strong>: Membrane protein extraction</li>
<li><strong>Autophagosome maturation</strong>: Post-formation fusion</li>
<li><strong>VCP-NPL4-UFD1 complex membership</strong>: Essential for function</li>
<li><strong>Protein-containing complex binding</strong>: Substrate extraction from complexes</li>
</ul>
<h4 id="non-core-functions-keep_as_non_core-2-annotations_2">Non-Core Functions (KEEP_AS_NON_CORE - 2 annotations)</h4>
<ul>
<li>Embryonic development (pleiotropic consequence of ERAD loss)</li>
</ul>
<h4 id="key-curation-decisions">Key Curation Decisions</h4>
<ul>
<li><strong>MODIFY</strong>: 4 generic "protein binding" → specific complex binding or polyubiquitin binding</li>
<li>All annotations well-supported by IBA phylogenetic inference + C. elegans validation</li>
</ul>
<h4 id="key-evidence_5">Key Evidence</h4>
<ul>
<li><strong>IBA evidence</strong>: AAA+ ATPase domain structure conserved across eukaryotes</li>
<li><strong>IGI evidence</strong>: Genetic interaction with ERAD pathway components</li>
<li><strong>IDA evidence</strong>: Co-IP studies identify CDC-48 protein partners</li>
</ul>
<p><strong>Clinical Relevance</strong>: VCP mutations cause inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD); VCP is potential cancer target.</p>
<hr />
<h3 id="22-bec-1-autophagy-initiator-and-pi3k-scaffold-45-annotations">2.2 BEC-1: Autophagy Initiator and PI3K Scaffold (45 annotations)</h3>
<p><strong>UniProt</strong>: O16351 | <strong>Human Ortholog</strong>: <a href="../../genes/human/BECN1/BECN1-ai-review.html">BECN1</a> | <strong>Key Function</strong>: Beclin 1 autophagy initiator</p>
<h4 id="core-autophagy-role">Core Autophagy Role</h4>
<p>BEC-1 is the C. elegans ortholog of mammalian <a href="../../genes/human/BECN1/BECN1-ai-review.html">BECN1</a> (Beclin 1), a critical scaffold protein in the VPS34 kinase complex. This complex initiates autophagy by generating phosphatidylinositol 3-phosphate (PI3P) at the phagophore.</p>
<h4 id="core-molecular-functions-accept-31-annotations">Core Molecular Functions (ACCEPT - 31 annotations)</h4>
<ul>
<li><strong>Autophagosome assembly</strong>: Scaffolds VPS34 complex at forming phagophore</li>
<li><strong>Phagophore assembly site localization</strong>: Recruits ATG machinery</li>
<li><strong>PI3K complex formation</strong>: Brings together catalytic VPS34 and regulatory subunits</li>
<li><strong>Endosomal trafficking coordination</strong>: Related autophagy and endocytic roles</li>
</ul>
<h4 id="pi3kc3-complexes">PI3KC3 Complexes</h4>
<p>BEC-1 participates in two distinct VPS34 complexes:</p>
<ol>
<li><strong>Class C-I</strong>: BEC-1 + VPS34 + VPS15 + ATG14 (autophagy-specific)</li>
<li><strong>Class C-II</strong>: BEC-1 + VPS34 + VPS15 + UVRAG (endocytic-focused)</li>
</ol>
<h4 id="selective-autophagy-functions">Selective Autophagy Functions</h4>
<ul>
<li><strong>Mitophagy</strong>: Selective degradation of damaged mitochondria</li>
<li><strong>Apoptotic cell clearance</strong>: Clearance of apoptotic corpses via autophagy</li>
<li><strong>Xenophagy</strong>: Autophagic degradation of intracellular pathogens</li>
<li><strong>Starvation autophagy</strong>: Activation upon nutrient deprivation</li>
</ul>
<h4 id="non-core-functions-keep_as_non_core-5-annotations">Non-Core Functions (KEEP_AS_NON_CORE - 5 annotations)</h4>
<ul>
<li>Germ cell proliferation (developmental role)</li>
<li>Dauer formation (developmental consequence)</li>
<li>Growth regulation (nutrient-sensing role)</li>
</ul>
<h4 id="key-curation-decision_3">Key Curation Decision</h4>
<ul>
<li><strong>MODIFY</strong>: 3 generic "protein binding" → "PI3K complex scaffolding" (more specific)</li>
</ul>
<h4 id="key-evidence_6">Key Evidence</h4>
<ul>
<li><strong>IBA evidence</strong>: Conserved beclin/VPS34 interaction across eukaryotes</li>
<li><strong>IMP evidence</strong>: <a href="../../genes/worm/bec-1/bec-1-ai-review.html">bec-1</a> mutation blocks autophagy formation (defective autophagosome assembly)</li>
<li><strong>IGI evidence</strong>: Genetic interaction with other ATG genes</li>
</ul>
<p><strong>Clinical Relevance</strong>: <a href="../../genes/human/BECN1/BECN1-ai-review.html">BECN1</a> is a tumor suppressor; mutations increase cancer risk; autophagy dysfunction implicated in neurodegeneration.</p>
<hr />
<h3 id="23-lgg-1-gabarap-autophagosomal-ubiquitin-like-modifier-49-annotations">2.3 LGG-1: GABARAP Autophagosomal Ubiquitin-like Modifier (49 annotations)</h3>
<p><strong>UniProt</strong>: Q9XYN3 | <strong>Human Ortholog</strong>: GABARAP/MAP1LC3B | <strong>Key Function</strong>: Autophagosomal ubiquitin-like protein</p>
<h4 id="lipidation-and-autophagy-biogenesis">Lipidation and Autophagy Biogenesis</h4>
<p>LGG-1 is the C. elegans GABARAP family member (closely related to mammalian LC3 and GABARAP). Unlike mammalian systems where LC3 and GABARAP have distinct roles, C. elegans uses:</p>
<ul>
<li><strong>LGG-1</strong>: Acts upstream, initiates autophagosome assembly</li>
<li><strong>LGG-2</strong>: Acts downstream, promotes autophagosome-lysosome fusion</li>
</ul>
<h4 id="core-molecular-functions-accept-35-annotations">Core Molecular Functions (ACCEPT - 35 annotations)</h4>
<ul>
<li><strong>Autophagosome assembly</strong>: PE-conjugated form defines autophagosomal membrane</li>
<li><strong>Phospholipid binding</strong>: PE binding on autophagosomal membrane (via lipidation)</li>
<li><strong>Selective autophagy pathways</strong>: Substrate cargo recognition</li>
</ul>
<h4 id="lipidation-mechanism">Lipidation Mechanism</h4>
<p>LGG-1 undergoes distinctive post-translational modification:</p>
<ol>
<li><strong>Proteolytic processing</strong>: ATG4-mediated cleavage exposes C-terminal Gly</li>
<li><strong>Ubiquitin-like conjugation</strong>: ATG7/ATG3 conjugate PE (phosphatidylethanolamine) to C-terminus</li>
<li><strong>Membrane localization</strong>: Lipidation drives autophagosomal membrane insertion</li>
<li><strong>Cargo recruitment</strong>: LIR (LC3-Interacting Region) motifs on cargo proteins bind LGG-1</li>
</ol>
<h4 id="selective-autophagy-roles">Selective Autophagy Roles</h4>
<ul>
<li><strong>Xenophagy</strong>: Autophagic degradation of bacteria (PMID:30880001)</li>
<li><strong>Mitophagy</strong>: Selective mitochondrial degradation</li>
<li><strong>LAP</strong>: LC3-Associated Phagocytosis for apoptotic cell clearance</li>
<li><strong>Allophagy</strong>: Selective degradation of paternal mitochondria (PMID:29255173)</li>
</ul>
<h4 id="non-core-functions-keep_as_non_core-8-annotations">Non-Core Functions (KEEP_AS_NON_CORE - 8 annotations)</h4>
<ul>
<li>Aging and lifespan effects</li>
<li>Stress response consequences</li>
<li>Necroptosis in specific contexts</li>
<li>Defense response to pathogens</li>
</ul>
<h4 id="key-curation-decision_4">Key Curation Decision</h4>
<ul>
<li><strong>REMOVE</strong>: GO:0050811 (GABA receptor binding) - nomenclature artifact from mammalian GABARAP discovery; no functional evidence in worms</li>
<li><strong>MODIFY</strong>: 4 generic "protein binding" → "protein-containing complex binding"</li>
</ul>
<h4 id="key-evidence_7">Key Evidence</h4>
<ul>
<li><strong>IBA evidence</strong>: Conserved GABARAP domain structure</li>
<li><strong>IMP evidence</strong>: <a href="../../genes/worm/lgg-1/lgg-1-ai-review.html">lgg-1</a> mutant shows defective autophagy</li>
<li><strong>IDA evidence</strong>: Localization studies show autophagosomal membrane recruitment</li>
</ul>
<p><strong>Clinical Relevance</strong>: LC3/GABARAP mutations associated with ALS and neurodegeneration; autophagy dysfunction in Alzheimer's and Parkinson's disease.</p>
<hr />
<h3 id="24-rpn-10-ubiquitin-receptor-in-19s-proteasome-14-annotations">2.4 RPN-10: Ubiquitin Receptor in 19S Proteasome (14 annotations)</h3>
<p><strong>UniProt</strong>: Q20461 | <strong>Human Ortholog</strong>: PSMD4 | <strong>Key Function</strong>: Proteasome ubiquitin receptor</p>
<h4 id="uim-domain-architecture">UIM Domain Architecture</h4>
<p>RPN-10 is a critical component of the 19S regulatory particle (cap) of the 26S proteasome. Contains two UIM (Ubiquitin-Interacting Motif) domains that:</p>
<ol>
<li><strong>Substrate recognition</strong>: Directly bind polyubiquitinated protein substrates</li>
<li><strong>Proteasome targeting</strong>: Deliver ubiquitinated proteins to proteasome active sites</li>
<li><strong>Deubiquitination coordination</strong>: Work with RPN-11 deubiquitinase</li>
</ol>
<h4 id="dual-module-proteasome-receptor">Dual-Module Proteasome Receptor</h4>
<p>RPN-10 cooperates with complementary ubiquitin receptor RPN-13 (not reviewed here):</p>
<ul>
<li><strong>RPN-10</strong>: Rapid substrate binding and delivery</li>
<li><strong>RPN-13</strong>: Substrate deubiquitination coordination</li>
<li><strong>Substrate preference</strong>: RPN-10 prefers K48-linked polyubiquitin chains</li>
</ul>
<h4 id="core-molecular-functions-accept-11-annotations">Core Molecular Functions (ACCEPT - 11 annotations)</h4>
<ul>
<li><strong>Polyubiquitin-dependent protein binding</strong>: UIM domain substrate recognition</li>
<li><strong>Ubiquitin-dependent protein catabolism</strong>: Proteasome-mediated degradation</li>
<li><strong>Proteasome assembly</strong>: Structural role in 19S particle</li>
<li><strong>Proteasome complex membership</strong>: Component of 26S particle</li>
</ul>
<h4 id="biological-role-example">Biological Role Example</h4>
<p>RPN-10 recognizes misfolded TRA-2 protein destined for degradation:</p>
<ol>
<li><strong>Ubiquitin chain transfer</strong>: E3 ligase transfers K48-polyubiquitin chains to TRA-2</li>
<li><strong>RPN-10 recognition</strong>: UIM domains bind polyubiquitin chains</li>
<li><strong>Proteasome delivery</strong>: Transports to 19S particle catalytic core</li>
<li><strong>Degradation</strong>: 20S proteasome cleaves TRA-2 into peptides</li>
<li><strong>Sex determination</strong>: TRA-2 loss triggers male development pathway</li>
</ol>
<h4 id="non-core-functions-keep_as_non_core-2-annotations_3">Non-Core Functions (KEEP_AS_NON_CORE - 2 annotations)</h4>
<ul>
<li>Spermatogenesis (phenotypic consequence of TRA-2 degradation)</li>
</ul>
<h4 id="key-evidence_8">Key Evidence</h4>
<ul>
<li><strong>IBA evidence</strong>: UIM domain conservation across eukaryotes</li>
<li><strong>IMP evidence</strong>: <a href="../../genes/worm/rpn-10/rpn-10-ai-review.html">rpn-10</a> mutation causes TRA-2 substrate accumulation</li>
<li><strong>IDA evidence</strong>: Proteasome complex localization from biochemistry</li>
</ul>
<p><strong>Clinical Relevance</strong>: PSMD4 mutations associated with intellectual disability; proteasome dysfunction in neurodegenerative disease.</p>
<hr />
<h3 id="25-ufd-1-erad-substrate-processing-atpase-co-factor-18-annotations">2.5 UFD-1: ERAD Substrate Processing ATPase Co-factor (18 annotations)</h3>
<p><strong>UniProt</strong>: Q20818 | <strong>Human Ortholog</strong>: UFD1L | <strong>Key Function</strong>: ERAD pathway component</p>
<h4 id="cdc-48-complex-partner">CDC-48 Complex Partner</h4>
<p>UFD-1 functions as an essential adapter/co-factor for CDC-48 in ERAD. While CDC-48 provides the unfoldase motor activity, UFD-1:</p>
<ol>
<li><strong>Substrate delivery</strong>: Recognizes ubiquitinated ERAD substrates</li>
<li><strong>AAA+ ATPase activation</strong>: Stimulates CDC-48 ATPase activity</li>
<li><strong>Membrane docking</strong>: Tethers CDC-48 to ER membrane</li>
<li><strong>Protein unfolding</strong>: Assists in substrate extraction from lipid bilayer</li>
</ol>
<h4 id="structural-features">Structural Features</h4>
<p>UFD-1 functions as part of UFD1L-NPL4 heterodimer complex:</p>
<ul>
<li><strong>UFD-1</strong>: N-terminal ubiquitin-like domain + central coiled-coil</li>
<li><strong>NPL-4</strong>: C-terminal zinc finger for substrate binding</li>
<li><strong>Heterodimer function</strong>: Required for efficient CDC-48 recruitment and activation</li>
</ul>
<h4 id="core-molecular-functions-accept-13-annotations">Core Molecular Functions (ACCEPT - 13 annotations)</h4>
<ul>
<li><strong>Polyubiquitin binding</strong>: Recognizes K63-linked polyubiquitin chains</li>
<li><strong>Protein-containing complex binding</strong>: ERAD complex (CDC-48/UFD-1/NPL-4)</li>
<li><strong>ERAD pathway participation</strong>: Extracts misfolded ER proteins</li>
<li><strong>Chromatin-associated protein degradation</strong>: S-phase progression</li>
</ul>
<h4 id="biological-role">Biological Role</h4>
<p>UFD-1 enables CDC-48 to:</p>
<ol>
<li><strong>Extract ERAD substrates</strong> from ER membrane</li>
<li><strong>Unfold proteins</strong> for proteasomal processing</li>
<li><strong>Degrade misfolded proteins</strong> accumulated during ER stress</li>
<li><strong>Protect genome stability</strong> via degradation of replication-associated proteins</li>
</ol>
<h4 id="non-core-functions-keep_as_non_core-2-annotations_4">Non-Core Functions (KEEP_AS_NON_CORE - 2 annotations)</h4>
<ul>
<li>Chromatin-associated degradation (S-phase specific)</li>
</ul>
<h4 id="key-curation-decision_5">Key Curation Decision</h4>
<ul>
<li><strong>MODIFY</strong>: 3 generic "protein binding" → GO:0034098 "AAA-ATPase complex component"</li>
</ul>
<h4 id="key-evidence_9">Key Evidence</h4>
<ul>
<li><strong>IBA evidence</strong>: Conserved UFC1-NPL4 interaction</li>
<li><strong>IMP evidence</strong>: <a href="../../genes/worm/ufd-1/ufd-1-ai-review.html">ufd-1</a> mutation blocks ERAD (substrate accumulation)</li>
<li><strong>IPI evidence</strong>: Co-IP studies confirm complex membership</li>
</ul>
<p><strong>Clinical Relevance</strong>: UFD1L mutations associated with neurodegeneration; ERAD dysfunction in Alzheimer's and Parkinson's disease.</p>
<hr />
<h3 id="26-atg-18-pi3p-effector-and-autophagy-regulator-37-annotations">2.6 ATG-18: PI3P Effector and Autophagy Regulator (37 annotations)</h3>
<p><strong>UniProt</strong>: O16466 | <strong>Human Ortholog</strong>: WIPI1/2 | <strong>Key Function</strong>: PIP3 effector autophagy protein</p>
<h4 id="pi3p-recognition-domain">PI3P Recognition Domain</h4>
<p>ATG-18 is the C. elegans ortholog of mammalian WIPI1 and WIPI2 (WD-Repeat Protein Interacting with Phosphoinositides). Contains:</p>
<ol>
<li><strong>FRRG motif</strong> (Phenylalanine and Arginine-Rich Regions): Direct PI3P recognition</li>
<li><strong>WD-repeat domains</strong>: Protein-protein interaction scaffold</li>
<li><strong>PROPPIN structure</strong>: Class of PIP3-binding proteins</li>
</ol>
<h4 id="autophagy-pathway-position">Autophagy Pathway Position</h4>
<p>ATG-18 acts downstream of BEC-1's PI3P generation:</p>
<ol>
<li><strong>BEC-1 creates PI3P</strong>: VPS34 kinase generates PI3P at phagophore membrane</li>
<li><strong>ATG-18 recruitment</strong>: Binds PI3P via FRRG motif</li>
<li><strong>ATG machinery assembly</strong>: Recruits downstream autophagy factors</li>
<li><strong>Apoptotic cell clearance</strong>: Also functions in LAP pathway</li>
</ol>
<h4 id="core-molecular-functions-accept-21-annotations_1">Core Molecular Functions (ACCEPT - 21 annotations)</h4>
<ul>
<li><strong>Phosphoinositide binding</strong>: PI3P, PI4P, PI5P, PI(3,5)P2 recognition via FRRG motif</li>
<li><strong>Adaptor/effector activity</strong>: Links PI3P to autophagy machinery</li>
<li><strong>Selective autophagy roles</strong>: Xenophagy, mitophagy, nucleophagy</li>
</ul>
<h4 id="distinct-from-epg-6">Distinct from EPG-6</h4>
<p>C. elegans has two PROPPIN family members with overlapping but distinct roles:</p>
<ul>
<li><strong>ATG-18</strong>: Early autophagosome formation, apoptotic cell clearance</li>
<li><strong>EPG-6</strong>: Autophagosome maturation and closure (not reviewed here)</li>
</ul>
<h4 id="selective-autophagy-functions_1">Selective Autophagy Functions</h4>
<ul>
<li><strong>Xenophagy</strong>: Bacterial clearance via autophagy</li>
<li><strong>Mitophagy</strong>: Selective mitochondrial degradation</li>
<li><strong>Nucleophagy</strong>: Selective degradation of nucleus-derived bodies</li>
<li><strong>Glycophagy</strong>: Selective glycogen degradation</li>
<li><strong>LAP (LC3-Associated Phagocytosis)</strong>: Apoptotic cell clearance</li>
</ul>
<h4 id="non-core-functions-keep_as_non_core-9-annotations_2">Non-Core Functions (KEEP_AS_NON_CORE - 9 annotations)</h4>
<ul>
<li>Germ cell proliferation (developmental role)</li>
<li>Embryonic development (developmental consequence)</li>
<li>Lifespan effects (cellular homeostasis consequence)</li>
<li>Dauer formation (developmental/environmental response)</li>
</ul>
<h4 id="key-curation-decision_6">Key Curation Decision</h4>
<ul>
<li><strong>MARK_AS_OVER_ANNOTATED</strong>: GO:0008289 (lipid binding) - too general; specific phosphoinositide terms preferred</li>
</ul>
<h4 id="key-evidence_10">Key Evidence</h4>
<ul>
<li><strong>IBA evidence</strong>: FRRG motif conservation across eukaryotes</li>
<li><strong>IDA evidence</strong>: Autophagosomal membrane localization from microscopy</li>
<li><strong>IMP evidence</strong>: <a href="../../genes/worm/atg-18/atg-18-ai-review.html">atg-18</a> mutants show autophagy defects</li>
</ul>
<p><strong>Clinical Relevance</strong>: WIPI1/2 mutations associated with neurodegeneration; autophagy dysfunction in ALS and Parkinson's disease.</p>
<hr />
<h2 id="part-3-longevity-and-proteostasis-integration">Part 3: Longevity and Proteostasis Integration</h2>
<h3 id="31-daf-2-insulinigf-receptor-upstream-of-daf-16-88-annotations">3.1 DAF-2: Insulin/IGF Receptor Upstream of DAF-16 (88 annotations)</h3>
<p><strong>UniProt</strong>: Q968Y9 | <strong>Human Ortholog</strong>: INSR | <strong>Key Function</strong>: Insulin and IGF-1 receptor</p>
<h4 id="master-longevity-switch">Master Longevity Switch</h4>
<p>DAF-2 is the fundamental signal transducer controlling the balance between:</p>
<ol>
<li><strong>Growth and reproduction</strong> (high DAF-2 signaling)</li>
<li><strong>Longevity and stress resistance</strong> (low DAF-2 signaling)</li>
</ol>
<p>The <a href="../../genes/worm/daf-2/daf-2-ai-review.html">daf-2</a> gene was first discovered through the "dauer formation" phenotype: <a href="../../genes/worm/daf-2/daf-2-ai-review.html">daf-2</a> mutants form non-feeding, stress-resistant larvae that live much longer than normal.</p>
<h4 id="insulinigf-signaling-cascade">Insulin/IGF Signaling Cascade</h4>
<p>DAF-2 activation triggers:</p>
<ol>
<li><strong>Receptor tyrosine kinase autophosphorylation</strong>: On ligand binding</li>
<li><strong>IRS protein recruitment</strong>: DAF-4 (IRS ortholog) phosphorylation</li>
<li><strong>PI3K activation</strong>: AGE-1 (PI3K) and AKT-1 (PKB) phosphorylation</li>
<li><strong>DAF-16 nuclear export</strong>: FOXO transcription factor sequestered in cytoplasm</li>
</ol>
<h4 id="nuclear-exclusion-of-daf-16">Nuclear Exclusion of DAF-16</h4>
<p>Under normal (nutrient-rich) conditions:</p>
<ol>
<li>DAF-2 activation → AKT-1 phosphorylation</li>
<li>AKT-1 phosphorylates DAF-16 at three sites</li>
<li>Phosphorylated DAF-16 binds 14-3-3 proteins</li>
<li>14-3-3 proteins sequester DAF-16 in cytoplasm</li>
<li>Stress response genes remain repressed</li>
</ol>
<h4 id="proteostasis-role">Proteostasis Role</h4>
<p>DAF-2 signaling affects proteostasis through:</p>
<ol>
<li><strong>HSF-1 activation</strong>: Reduced DAF-2 → increased HSF-1 activity</li>
<li><strong>Autophagy upregulation</strong>: DAF-16 activates autophagy genes (<a href="../../genes/worm/bec-1/bec-1-ai-review.html">bec-1</a>, <a href="../../genes/worm/lgg-1/lgg-1-ai-review.html">lgg-1</a>, <a href="../../genes/worm/atg-18/atg-18-ai-review.html">atg-18</a>)</li>
<li><strong>ERAD enhancement</strong>: Enhanced protein degradation capacity</li>
<li><strong>Longevity extension</strong>: Improved proteostasis capacity extends lifespan</li>
</ol>
<h4 id="key-curation-notes">Key Curation Notes</h4>
<ul>
<li><strong>144 annotations</strong>: Largest annotated gene in Priority 3 (reflects major lifespan role)</li>
<li><strong>Non-core distinction</strong>: Many annotations reflect downstream effects rather than core DAF-2 function</li>
</ul>
<h4 id="key-evidence_11">Key Evidence</h4>
<ul>
<li><strong>IMP evidence</strong>: <a href="../../genes/worm/daf-2/daf-2-ai-review.html">daf-2</a> mutants show dramatic lifespan extension and dauer formation</li>
<li><strong>IDA evidence</strong>: Receptor tyrosine kinase activity confirmed</li>
<li><strong>IPI evidence</strong>: Interaction with downstream signaling components</li>
</ul>
<p><strong>Clinical Relevance</strong>: Insulin signaling dysregulation in diabetes, metabolic syndrome, and aging; IGF signaling in cancer (stimulatory).</p>
<hr />
<h3 id="32-daf-16-foxo-transcription-factor-master-regulator-144-annotations">3.2 DAF-16: FOXO Transcription Factor Master Regulator (144 annotations)</h3>
<p><strong>UniProt</strong>: O16850 | <strong>Human Ortholog</strong>: FOXO3 | <strong>Key Function</strong>: FOXO transcription factor</p>
<h4 id="central-hub-of-longevity-pathway">Central Hub of Longevity Pathway</h4>
<p>DAF-16 is the primary transcriptional effector of longevity and stress responses in C. elegans. Activates &gt;500 genes including:</p>
<ol>
<li><strong>Stress response genes</strong>: Heat shock proteins, detoxification enzymes</li>
<li><strong>Autophagy genes</strong>: <a href="../../genes/worm/bec-1/bec-1-ai-review.html">bec-1</a>, <a href="../../genes/worm/lgg-1/lgg-1-ai-review.html">lgg-1</a>, <a href="../../genes/worm/atg-18/atg-18-ai-review.html">atg-18</a>, epg-genes</li>
<li><strong>Metabolic genes</strong>: Fat oxidation, lipid metabolism</li>
<li><strong>DNA repair genes</strong>: Enhanced genomic maintenance</li>
<li><strong>Immune genes</strong>: Coordinated defense response</li>
</ol>
<h4 id="nuclear-localization-and-phosphorylation">Nuclear Localization and Phosphorylation</h4>
<p>DAF-16's nuclear localization is the key regulatory step:</p>
<p><strong>Inactive (normal conditions)</strong>:<br />
- DAF-2 signaling active → AKT-1 phosphorylates DAF-16<br />
- Phosphorylated DAF-16 binds 14-3-3 proteins<br />
- Sequestered in cytoplasm</p>
<p><strong>Active (stress or <a href="../../genes/worm/daf-2/daf-2-ai-review.html">daf-2</a> mutation)</strong>:<br />
- DAF-2 signaling reduced → AKT-1 inactive<br />
- DAF-16 dephosphorylation → 14-3-3 release<br />
- Nuclear accumulation → target gene activation</p>
<h4 id="dna-binding-specificity">DNA Binding Specificity</h4>
<p>DAF-16 binds:</p>
<ol>
<li><strong>DAF-binding elements (DBE)</strong>: TTTGTTTAC consensus sequence</li>
<li><strong>Forkhead DNA-binding domain</strong>: Sequence-specific recognition</li>
<li><strong>Co-activators</strong>: Pioneer factors and chromatin remodelers</li>
</ol>
<h4 id="proteostasis-target-genes">Proteostasis Target Genes</h4>
<p>DAF-16 directly activates genes for:</p>
<ul>
<li><strong>Protein folding</strong>: <a href="../../genes/worm/hsp-16.2/hsp-16.2-ai-review.html">hsp-16.2</a>, hsp-70, <a href="../../genes/worm/daf-21/daf-21-ai-review.html">daf-21</a> (HSP90)</li>
<li><strong>Protein degradation</strong>: ubiquitin-conjugating enzymes, E3 ligases</li>
<li><strong>Autophagy</strong>: BEC-1, LGG-1, ATG-18, SEPA-1 (cargo receptor)</li>
<li><strong>ERAD</strong>: CDC-48, UFD-1, components of ER quality control</li>
</ul>
<h4 id="crosstalk-with-other-pathways">Crosstalk with Other Pathways</h4>
<p>DAF-16 integrates signals from:</p>
<ol>
<li><strong>DAF-2/Insulin signaling</strong>: Primary negative regulation via AKT-1</li>
<li><strong>AMPK signaling</strong>: AAK-2 kinase phosphorylates DAF-16 for activation</li>
<li><strong>Mitochondrial stress</strong>: UPR-mt signals enhance DAF-16 activity</li>
<li><strong>Oxidative stress</strong>: SKN-1 (Nrf2) cooperates with DAF-16</li>
</ol>
<h4 id="tissue-specific-functions">Tissue-Specific Functions</h4>
<ul>
<li><strong>Intestine</strong>: Primary energy storage tissue; DAF-16 regulates lipid metabolism</li>
<li><strong>Nervous system</strong>: DAF-16 in neurons regulates stress response signaling to intestine</li>
<li><strong>Germline</strong>: DAF-16 affects fecundity and reproductivity (trade-off with longevity)</li>
</ul>
<h4 id="key-annotation-summary">Key Annotation Summary</h4>
<ul>
<li><strong>144 total annotations</strong>: Reflects central hub role</li>
<li><strong>Comprehensive transcription factor functions</strong>: DNA binding, transcriptional activation</li>
<li><strong>Extensive non-core functions</strong>: Many represent downstream phenotypic effects</li>
</ul>
<h4 id="key-evidence_12">Key Evidence</h4>
<ul>
<li><strong>IMP evidence</strong>: daf-16 mutants lack lifespan extension in <a href="../../genes/worm/daf-2/daf-2-ai-review.html">daf-2</a> background</li>
<li><strong>IDA evidence</strong>: FOXO-GFP imaging shows stress-induced nuclear accumulation</li>
<li><strong>IPI evidence</strong>: Chromatin immunoprecipitation of DAF-16 target sites</li>
</ul>
<p><strong>Clinical Relevance</strong>: FOXO3 dysfunction in aging, neurodegeneration, cancer; FOXO activation extends lifespan in diverse organisms.</p>
<hr />
<h3 id="33-skn-1-nrf2-ortholog-and-oxidative-stress-master-regulator-74-annotations">3.3 SKN-1: Nrf2 Ortholog and Oxidative Stress Master Regulator (74 annotations)</h3>
<p><strong>UniProt</strong>: P34707 | <strong>Human Ortholog</strong>: <a href="../../genes/human/NFE2L2/NFE2L2-ai-review.html">NFE2L2</a> | <strong>Key Function</strong>: CNC-family bZIP transcription factor</p>
<h4 id="oxidative-stress-response-hub">Oxidative Stress Response Hub</h4>
<p>SKN-1 is the C. elegans ortholog of mammalian NRF2 (Nuclear Factor Erythroid 2-Related Factor 2). Activates:</p>
<ol>
<li><strong>Phase I detoxification genes</strong>: Cytochrome P450s, monooxygenases</li>
<li><strong>Phase II detoxification genes</strong>: Glutathione S-transferases, antioxidant enzymes</li>
<li><strong>Phase III transporters</strong>: Xenobiotic pumps</li>
<li><strong>Antioxidant genes</strong>: SOD, catalase, thioredoxin</li>
<li><strong>Proteostasis genes</strong>: HSP90, HSP70, proteasome components</li>
</ol>
<h4 id="nuclear-localization-regulation">Nuclear Localization Regulation</h4>
<p>SKN-1 nuclear entry is controlled by:</p>
<ol>
<li><strong>GSK-3 kinase</strong>: Phosphorylates SKN-1, prevents nuclear entry</li>
<li><strong>IIS pathway suppression</strong>: Reduced DAF-2 → reduced AKT-1 → reduced GSK-3 activity</li>
<li><strong>Stress signaling</strong>: Oxidative stress, xenobiotic exposure → reduced GSK-3</li>
<li><strong>PMK-1 (p38 MAPK)</strong>: Phosphorylates SKN-1 for activation</li>
</ol>
<h4 id="antioxidant-gene-network">Antioxidant Gene Network</h4>
<p>SKN-1 target genes include:</p>
<ul>
<li><strong>SOD isoforms</strong>: sod-2 (Mn-SOD), sod-3 (Fe-SOD)</li>
<li><strong>Glutathione enzymes</strong>: GST enzymes for xenobiotic conjugation</li>
<li><strong>Thioredoxin system</strong>: TRX-1, TRXR-1 (thioredoxin reductase)</li>
<li><strong>Phase I detoxification</strong>: CYP genes for toxic metabolite activation</li>
<li><strong>Stress response chaperones</strong>: Complement HSF-1-activated genes</li>
</ul>
<h4 id="proteostasis-integration">Proteostasis Integration</h4>
<p>SKN-1 coordinates oxidative stress responses with proteostasis:</p>
<ol>
<li><strong>ROS production</strong> from misfolded protein aggregates</li>
<li><strong>ROS signaling</strong> activates SKN-1</li>
<li><strong>SKN-1 activates antioxidants + proteostasis genes</strong></li>
<li><strong>Coordinated response</strong>: ROS suppression + protein clearance</li>
</ol>
<h4 id="cross-pathway-regulation">Cross-Pathway Regulation</h4>
<p>SKN-1 is activated by multiple stress pathways:</p>
<ol>
<li><strong>Oxidative stress</strong>: Direct ROS-mediated mechanism</li>
<li><strong>Immune response</strong>: PMK-1 (p38 MAPK) phosphorylation</li>
<li><strong>Longevity signaling</strong>: DAF-16 cooperates with SKN-1</li>
<li><strong>ER stress</strong>: UPR-ER signaling enhances SKN-1 activity</li>
<li><strong>Mitochondrial stress</strong>: UPR-mt signals enhance SKN-1</li>
</ol>
<h4 id="recent-cross-project-review">Recent Cross-Project Review</h4>
<p>SKN-1 was reviewed in CAEEL_SURVEILLANCE_IMMUNITY project (Priority 1). This CAEEL_PROTEOSTASIS review confirms:</p>
<ul>
<li>Core transcription factor functions (DNA binding, activation)</li>
<li>Integration with proteostasis network (HSP, proteasome genes)</li>
<li>Distinction from peripheral immune functions (which are SKN-1-mediated but non-core to SKN-1 itself)</li>
</ul>
<h4 id="key-evidence_13">Key Evidence</h4>
<ul>
<li><strong>IMP evidence</strong>: <a href="../../genes/worm/skn-1/skn-1-ai-review.html">skn-1</a> mutants show increased ROS and decreased longevity</li>
<li><strong>IDA evidence</strong>: FOXO-GFP shows stress-induced nuclear accumulation</li>
<li><strong>IPI evidence</strong>: Interaction with GSK-3, PMK-1, and other regulators</li>
</ul>
<p><strong>Clinical Relevance</strong>: NRF2 dysregulation in neurodegeneration, cancer, and aging; NRF2 activators are therapeutic targets.</p>
<hr />
<h3 id="34-sir-21-nad-dependent-sirtuin-deacetylase-42-annotations">3.4 SIR-2.1: NAD+-Dependent Sirtuin Deacetylase (42 annotations)</h3>
<p><strong>UniProt</strong>: Q21921 | <strong>Human Ortholog</strong>: <a href="../../genes/human/SIRT1/SIRT1-ai-review.html">SIRT1</a> | <strong>Key Function</strong>: NAD+-dependent histone/protein deacetylase</p>
<h4 id="nad-metabolism-and-aging">NAD+ Metabolism and Aging</h4>
<p>SIR-2.1 (ortholog of mammalian <a href="../../genes/human/SIRT1/SIRT1-ai-review.html">SIRT1</a>) is an NAD+-dependent deacetylase that:</p>
<ol>
<li><strong>Consumes NAD+</strong>: Cleaves NAD+ during deacetylation reaction</li>
<li><strong>Energetic sensor</strong>: NAD+/NADH ratio reflects cellular energy status</li>
<li><strong>Longevity effector</strong>: Extended lifespan in caloric restriction requires SIR-2.1</li>
</ol>
<h4 id="histone-deacetylation-mechanism">Histone Deacetylation Mechanism</h4>
<p>SIR-2.1 removes acetyl groups from lysines on:</p>
<ol>
<li><strong>Histones H3 and H4</strong>: Affects chromatin structure and gene expression</li>
<li><strong>Non-histone proteins</strong>: Transcription factors, metabolic enzymes</li>
<li><strong>Deacetylation consequence</strong>: Generally transcriptional silencing (except for DAF-16)</li>
</ol>
<h4 id="transcriptional-targets">Transcriptional Targets</h4>
<p>SIR-2.1 deacetylates and activates:</p>
<ol>
<li><strong>DAF-16 (FOXO)</strong>: SIR-2.1 deacetylates DAF-16 → enhanced activity</li>
<li><strong>HSF-1</strong>: Increased heat shock gene expression</li>
<li><strong>Metabolic enzymes</strong>: Enhanced NADP-dependent pathways</li>
<li><strong>Autophagy genes</strong>: Enhanced autophagy upon caloric restriction</li>
</ol>
<h4 id="proteostasis-role_1">Proteostasis Role</h4>
<p>SIR-2.1 enhances proteostasis through:</p>
<ol>
<li><strong>Chromatin remodeling</strong>: Makes proteostasis genes more accessible</li>
<li><strong>DAF-16 activation</strong>: SIR-2.1 deacetylates and activates DAF-16</li>
<li><strong>Metabolic shift</strong>: Reduced ATP production → autophagy upregulation</li>
<li><strong>Mitochondrial function</strong>: Regulates mitochondrial biogenesis</li>
</ol>
<h4 id="caloric-restriction-mechanism">Caloric Restriction Mechanism</h4>
<p>During nutrient scarcity:</p>
<ol>
<li><strong>Energy depletion</strong> → NAD+ accumulation</li>
<li><strong>SIR-2.1 activation</strong> → Histone deacetylation</li>
<li><strong>Chromatin condensation</strong> → Longevity gene expression</li>
<li><strong>Proteostasis enhancement</strong> → Protein quality control upregulation</li>
<li><strong>Lifespan extension</strong> → Stress resistance and longevity</li>
</ol>
<h4 id="interactor-network">Interactor Network</h4>
<p>SIR-2.1 physically associates with:</p>
<ol>
<li><strong>DAF-16</strong>: Deacetylation increases FOXO activity</li>
<li><strong>HSF-1</strong>: Cooperative proteostasis regulation</li>
<li><strong>Nuclear histone deacetylase complex</strong>: Chromatin regulation</li>
<li><strong>Metabolic enzymes</strong>: Protein acetylation in cytoplasm</li>
</ol>
<h4 id="key-annotations">Key Annotations</h4>
<ul>
<li><strong>42 total annotations</strong>: Smaller than major transcription factors but well-characterized</li>
<li><strong>Core deacetylase functions</strong>: NAD+-dependent deacetylation</li>
<li><strong>Acetyl-CoA consumption</strong>: Uses acetyl-CoA as substrate</li>
<li><strong>Protein complex membership</strong>: Part of histone deacetylase complex</li>
</ul>
<h4 id="key-evidence_14">Key Evidence</h4>
<ul>
<li><strong>IDA evidence</strong>: Biochemical assays of deacetylase activity</li>
<li><strong>IMP evidence</strong>: <a href="../../genes/worm/sir-2.1/sir-2.1-ai-review.html">sir-2.1</a> mutant fails to extend lifespan under caloric restriction</li>
<li><strong>IPI evidence</strong>: Co-IP with DAF-16 and other target proteins</li>
</ul>
<p><strong>Clinical Relevance</strong>: <a href="../../genes/human/SIRT1/SIRT1-ai-review.html">SIRT1</a> dysregulation in aging, neurodegeneration, metabolic disease; <a href="../../genes/human/SIRT1/SIRT1-ai-review.html">SIRT1</a> activators (resveratrol) are in development.</p>
<hr />
<h3 id="35-aak-2-ampk-alpha-kinase-and-energy-sensor-31-annotations">3.5 AAK-2: AMPK Alpha Kinase and Energy Sensor (31 annotations)</h3>
<p><strong>UniProt</strong>: Q9N4I7 | <strong>Human Ortholog</strong>: PRKAA2 | <strong>Key Function</strong>: AMP-activated protein kinase alpha catalytic subunit</p>
<h4 id="energy-sensor-in-proteostasis">Energy Sensor in Proteostasis</h4>
<p>AAK-2 is the C. elegans ortholog of mammalian AMPK α (AMP-activated Protein Kinase alpha), a master metabolic switch activated by:</p>
<ol>
<li><strong>Energy depletion</strong>: High AMP/ATP ratio</li>
<li><strong>Nutrient scarcity</strong>: Amino acid starvation</li>
<li><strong>Oxidative stress</strong>: ROS production</li>
<li><strong>Exercise/stress</strong>: Physical stress signals</li>
</ol>
<h4 id="ampk-kinase-cascade">AMPK Kinase Cascade</h4>
<p>AAK-2 is the catalytic component of a heterotrimer:</p>
<ul>
<li><strong>AAK-2</strong>: Catalytic α-subunit (protein kinase)</li>
<li><strong>PAR-4</strong>: Scaffolding β-subunit (activates AAK-2)</li>
<li><strong>AAK-1</strong>: Regulatory γ-subunit (senses AMP)</li>
</ul>
<h4 id="target-phosphorylation">Target Phosphorylation</h4>
<p>AAK-2 phosphorylates:</p>
<ol>
<li><strong>DAF-16 (FOXO)</strong>: Activation during energy stress</li>
<li><strong>TSC2</strong>: Inhibits mTOR pathway (protein synthesis suppression)</li>
<li><strong>PGC-1α</strong>: Mitochondrial biogenesis (alternative in mammals)</li>
<li><strong>ULK1</strong>: Autophagy initiation kinase</li>
</ol>
<h4 id="proteostasis-role_2">Proteostasis Role</h4>
<p>AAK-2 enhances proteostasis through:</p>
<ol>
<li><strong>DAF-16 activation</strong>: Phosphorylates DAF-16 for nuclear localization</li>
<li><strong>Autophagy induction</strong>: Activates ULK1 (ATG1 in worms)</li>
<li><strong>mTOR inhibition</strong>: Suppresses protein synthesis (conserves ATP)</li>
<li><strong>Metabolic switch</strong>: Activates fatty acid oxidation (generates ATP)</li>
</ol>
<h4 id="nutrient-sensing-integration">Nutrient Sensing Integration</h4>
<p>AAK-2 coordinates cellular responses to nutrient scarcity:</p>
<ol>
<li><strong>Amino acid starvation</strong> → GCN2 (general control non-derepressible) activation</li>
<li><strong>Glucose depletion</strong> → AAK-2 activation via AMP/ATP ratio</li>
<li><strong>Lipid scarcity</strong> → Mitochondrial dysfunction → AAK-2 activation</li>
<li><strong>Convergent output</strong>: Autophagy upregulation + protein synthesis inhibition</li>
</ol>
<h4 id="stress-integration">Stress Integration</h4>
<p>AAK-2 integrates multiple stress signals:</p>
<ul>
<li><strong>Oxidative stress</strong>: ROS-mediated AAK-2 activation</li>
<li><strong>Heat stress</strong>: AAK-2 enhances HSF-1-mediated responses</li>
<li><strong>Infection</strong>: Immune response integration with AAK-2</li>
<li><strong>Caloric restriction</strong>: AAK-2 essential for lifespan extension</li>
</ul>
<h4 id="key-annotations_1">Key Annotations</h4>
<ul>
<li><strong>31 total annotations</strong>: Smaller than major transcription factors</li>
<li><strong>Core kinase functions</strong>: Protein kinase activity, ATP hydrolysis</li>
<li><strong>Target phosphorylation</strong>: DAF-16, TSC, ULK-like kinases</li>
</ul>
<h4 id="key-evidence_15">Key Evidence</h4>
<ul>
<li><strong>IMP evidence</strong>: <a href="../../genes/worm/aak-2/aak-2-ai-review.html">aak-2</a> mutants show reduced lifespan and stress sensitivity</li>
<li><strong>IDA evidence</strong>: Biochemical kinase assays</li>
<li><strong>IPI evidence</strong>: Interactions with AMPK complex components</li>
</ul>
<p><strong>Clinical Relevance</strong>: AMPK activation by metformin and AICAR is therapeutic approach for metabolic disease, aging, neurodegeneration.</p>
<hr />
<h3 id="36-hlh-30-tfeb-ortholog-autophagy-and-lysosome-master-regulator-42-annotations">3.6 HLH-30: TFEB Ortholog Autophagy and Lysosome Master Regulator (42 annotations)</h3>
<p><strong>UniProt</strong>: H2KZZ2 | <strong>Human Ortholog</strong>: TFEB | <strong>Key Function</strong>: bHLH transcription factor for autophagy and lysosomal biogenesis</p>
<h4 id="master-autophagy-lysosome-regulator">Master Autophagy-Lysosome Regulator</h4>
<p>HLH-30 is the C. elegans ortholog of mammalian TFEB (Transcription Factor EB), a major transcriptional regulator of:</p>
<ol>
<li><strong>Autophagy genes</strong>: ATG genes, autophagy initiation machinery</li>
<li><strong>Lysosomal genes</strong>: Lysosomal hydrolases, membrane proteins, v-ATPase</li>
<li><strong>Lysosomal biogenesis</strong>: Expansion of lysosomal capacity</li>
<li><strong>Autophagic flux</strong>: Autophagosome-lysosome fusion</li>
</ol>
<h4 id="clear-network">CLEAR Network</h4>
<p>HLH-30 activates the CLEAR (Coordinated Lysosomal Expression And Regulation) network, including:</p>
<ul>
<li><strong>Lysosomal enzymes</strong>: Acid phosphatase, proteases, glycosidases</li>
<li><strong>Membrane proteins</strong>: v-ATPase subunits, LAMP proteins</li>
<li><strong>Autophagy machinery</strong>: ATG genes</li>
<li><strong>Transcription factors</strong>: Other coordinated regulators</li>
</ul>
<h4 id="activation-pathways">Activation Pathways</h4>
<p>HLH-30 nuclear localization is induced by:</p>
<ol>
<li><strong>Starvation</strong>: Nutrient deprivation → TFEB nuclear accumulation</li>
<li><strong>Infection</strong>: Pathogenic bacteria/fungi trigger HLH-30 activation</li>
<li><strong>Heat stress</strong>: HSF-1 cooperates with HLH-30</li>
<li><strong>Calcium signaling</strong>: Ca2+ fluctuations → nuclear import</li>
<li><strong>mTOR inhibition</strong>: Calcineurin dephosphorylation of HLH-30</li>
</ol>
<h4 id="proteostasis-integration_1">Proteostasis Integration</h4>
<p>HLH-30 coordinates autophagy-lysosomal clearance with stress responses:</p>
<ol>
<li><strong>Autophagy gene activation</strong>: <a href="../../genes/worm/bec-1/bec-1-ai-review.html">bec-1</a>, <a href="../../genes/worm/lgg-1/lgg-1-ai-review.html">lgg-1</a>, <a href="../../genes/worm/atg-18/atg-18-ai-review.html">atg-18</a> upregulation</li>
<li><strong>Lysosomal expansion</strong>: Increased lysosomal capacity for substrate degradation</li>
<li><strong>Protein aggregate clearance</strong>: Enhanced clearance of misfolded protein aggregates</li>
<li><strong>Pathogen immunity</strong>: HLH-30 drives antimicrobial defense during infection</li>
</ol>
<h4 id="stress-response-integration">Stress Response Integration</h4>
<p>HLH-30 is activated by multiple stresses:</p>
<ol>
<li><strong>Heat stress</strong>: Works with HSF-1 to coordinate autophagy + HSP response</li>
<li><strong>Infection</strong>: Bacterial/fungal pathogen detection triggers HLH-30</li>
<li><strong>Amino acid starvation</strong>: Autophagy essential for amino acid recycling</li>
<li><strong>Oxidative stress</strong>: Aggregate clearance reduces ROS burden</li>
</ol>
<h4 id="cross-project-review-status">Cross-Project Review Status</h4>
<p>HLH-30 was previously reviewed in:</p>
<ul>
<li><strong>CAEEL_SURVEILLANCE_IMMUNITY project</strong>: Immune response and pathogen defense roles</li>
<li><strong>CAEEL_MITOPHAGY project</strong>: Mitophagy regulation role</li>
</ul>
<p>Current CAEEL_PROTEOSTASIS review confirms:<br />
- Core autophagy-lysosomal biogenesis functions<br />
- Integration with heat shock and proteostasis pathways<br />
- Consistency with immune and mitochondrial quality control roles</p>
<h4 id="key-annotations_2">Key Annotations</h4>
<ul>
<li><strong>42 total annotations</strong>: Reflects broad regulatory role</li>
<li><strong>bHLH transcription factor functions</strong>: DNA binding, transcriptional activation</li>
<li><strong>Lysosomal biogenesis</strong>: Gene activation for lysosomal expansion</li>
<li><strong>Autophagy initiation</strong>: Direct ATG gene activation</li>
</ul>
<h4 id="key-evidence_16">Key Evidence</h4>
<ul>
<li><strong>IBA evidence</strong>: TFEB domain structure conserved across eukaryotes</li>
<li><strong>IMP evidence</strong>: <a href="../../genes/worm/hlh-30/hlh-30-ai-review.html">hlh-30</a> mutants show defective autophagy and pathogen sensitivity</li>
<li><strong>IGI evidence</strong>: Genetic interactions with stress response pathways</li>
<li><strong>IDA evidence</strong>: Nuclear localization changes during stress</li>
</ul>
<p><strong>Clinical Relevance</strong>: TFEB enhancement is therapeutic strategy for lysosomal storage diseases, neurodegeneration (Alzheimer's, Parkinson's); TFEB dysregulation in cancer.</p>
<hr />
<h2 id="part-4-integrated-network-and-clinical-implications">Part 4: Integrated Network and Clinical Implications</h2>
<h3 id="41-network-architecture-and-functional-modules">4.1 Network Architecture and Functional Modules</h3>
<h4 id="heat-shock-response-module-priority-1">Heat Shock Response Module (Priority 1)</h4>
<p>The HSR module provides <strong>rapid, transient</strong> stress response:</p>
<div class="codehilite"><pre><span></span><code><span class="n">Stress</span><span class="w"> </span><span class="n">Signal</span><span class="w"> </span><span class="p">(</span><span class="n">Heat</span><span class="p">,</span><span class="w"> </span><span class="n">misfolded</span><span class="w"> </span><span class="n">proteins</span><span class="p">)</span>
<span class="w">         </span><span class="err">↓</span>
<span class="w">    </span><span class="n">HSF</span><span class="o">-</span><span class="mh">1</span><span class="w"> </span><span class="p">(</span><span class="n">Master</span><span class="w"> </span><span class="n">TF</span><span class="p">)</span>
<span class="w">         </span><span class="err">↓</span>
<span class="w">  </span><span class="n">Chaperone</span><span class="w"> </span><span class="n">Activation</span>
<span class="w">  </span><span class="err">├─</span><span class="w"> </span><span class="n">HSP</span><span class="o">-</span><span class="mh">1</span><span class="w"> </span><span class="p">(</span><span class="n">cytosolic</span><span class="w"> </span><span class="n">HSP70</span><span class="p">)</span>
<span class="w">  </span><span class="err">├─</span><span class="w"> </span><span class="n">HSP</span><span class="o">-</span><span class="mh">4</span><span class="w"> </span><span class="p">(</span><span class="n">ER</span><span class="w"> </span><span class="n">BiP</span><span class="p">)</span>
<span class="w">  </span><span class="err">├─</span><span class="w"> </span><span class="n">HSP</span><span class="o">-</span><span class="mf">16.2</span><span class="w"> </span><span class="p">(</span><span class="k">small</span><span class="w"> </span><span class="n">HSP</span><span class="p">)</span>
<span class="w">  </span><span class="err">├─</span><span class="w"> </span><span class="n">HSP</span><span class="o">-</span><span class="mh">90</span><span class="p">,</span><span class="w"> </span><span class="n">DAF</span><span class="o">-</span><span class="mh">21</span><span class="w"> </span><span class="p">(</span><span class="n">HSP90s</span><span class="p">)</span>
<span class="w">  </span><span class="err">└─</span><span class="w"> </span><span class="n">Co</span><span class="o">-</span><span class="n">chaperones</span>
<span class="w">         </span><span class="err">↓</span>
<span class="w">  </span><span class="n">Rapid</span><span class="w"> </span><span class="n">protein</span><span class="w"> </span><span class="n">stabilization</span>
<span class="w">  </span><span class="n">Aggregate</span><span class="w"> </span><span class="n">prevention</span>
<span class="w">  </span><span class="n">Thermotolerance</span>
</code></pre></div>

<h4 id="protein-degradation-module-priority-2">Protein Degradation Module (Priority 2)</h4>
<p>The degradation module provides <strong>sustained</strong> protein clearance:</p>
<div class="codehilite"><pre><span></span><code>Misfolded Protein Recognition
         ├─ ER-mediated: CDC-48 + UFD-1
         │   ├─ ERAD substrate extraction
         │   └─ Proteasomal degradation
         │
         └─ Cytoplasmic: BEC-1 + LGG-1 + ATG-18
             ├─ Autophagosome formation
             └─ Lysosomal degradation
                 ↓
           RPN-10 coordinates ubiquitin recognition
           (both ERAD and autophagy pathways)
</code></pre></div>

<h4 id="longevity-proteostasis-integration-priority-3">Longevity-Proteostasis Integration (Priority 3)</h4>
<p>The longevity module provides <strong>adaptive</strong> long-term proteostasis:</p>
<div class="codehilite"><pre><span></span><code><span class="n">Energy</span><span class="o">/</span><span class="n">Stress</span><span class="w"> </span><span class="n">Status</span>
<span class="w">         </span><span class="err">├─</span><span class="w"> </span><span class="n">DAF</span><span class="mi">-2</span><span class="w"> </span><span class="p">(</span><span class="n">Insulin</span><span class="o">/</span><span class="n">IGF</span><span class="w"> </span><span class="n">receptor</span><span class="p">)</span>
<span class="w">         </span><span class="err">│</span><span class="w">   </span><span class="err">↓</span><span class="w"> </span><span class="p">[</span><span class="n">Nutrient</span><span class="w"> </span><span class="n">scarcity</span><span class="p">]</span>
<span class="w">         </span><span class="err">│</span><span class="w">   </span><span class="n">DAF</span><span class="mi">-16</span><span class="w"> </span><span class="n">nuclear</span><span class="w"> </span><span class="n">accumulation</span>
<span class="w">         </span><span class="err">│</span><span class="w">   </span><span class="p">(</span><span class="n">FOXO</span><span class="w"> </span><span class="n">transcription</span><span class="w"> </span><span class="n">factor</span><span class="p">)</span>
<span class="w">         </span><span class="err">│</span>
<span class="w">         </span><span class="err">├─</span><span class="w"> </span><span class="n">SKN</span><span class="mi">-1</span><span class="w"> </span><span class="p">(</span><span class="n">Oxidative</span><span class="w"> </span><span class="n">stress</span><span class="p">)</span>
<span class="w">         </span><span class="err">│</span><span class="w">   </span><span class="err">←</span><span class="w"> </span><span class="n">ROS</span><span class="w"> </span><span class="n">from</span><span class="w"> </span><span class="n">misfolded</span><span class="w"> </span><span class="n">aggregates</span>
<span class="w">         </span><span class="err">│</span><span class="w">   </span><span class="err">→</span><span class="w"> </span><span class="n">Antioxidant</span><span class="w"> </span><span class="o">+</span><span class="w"> </span><span class="n">proteostasis</span><span class="w"> </span><span class="n">genes</span>
<span class="w">         </span><span class="err">│</span>
<span class="w">         </span><span class="err">├─</span><span class="w"> </span><span class="n">SIR</span><span class="mf">-2.1</span><span class="w"> </span><span class="p">(</span><span class="n">NAD</span><span class="o">+</span><span class="w"> </span><span class="n">deacetylase</span><span class="p">)</span>
<span class="w">         </span><span class="err">│</span><span class="w">   </span><span class="err">←</span><span class="w"> </span><span class="n">Energy</span><span class="w"> </span><span class="n">depletion</span><span class="w"> </span><span class="p">(</span><span class="n">NAD</span><span class="o">+</span><span class="w"> </span><span class="err">↑</span><span class="p">)</span>
<span class="w">         </span><span class="err">│</span><span class="w">   </span><span class="err">→</span><span class="w"> </span><span class="n">Chromatin</span><span class="w"> </span><span class="n">remodeling</span><span class="w"> </span><span class="o">+</span><span class="w"> </span><span class="n">DAF</span><span class="mi">-16</span><span class="w"> </span><span class="n">activation</span>
<span class="w">         </span><span class="err">│</span>
<span class="w">         </span><span class="err">├─</span><span class="w"> </span><span class="n">AAK</span><span class="mi">-2</span><span class="w"> </span><span class="p">(</span><span class="n">AMPK</span><span class="w"> </span><span class="n">energy</span><span class="w"> </span><span class="n">sensor</span><span class="p">)</span>
<span class="w">         </span><span class="err">│</span><span class="w">   </span><span class="err">←</span><span class="w"> </span><span class="n">AMP</span><span class="o">/</span><span class="n">ATP</span><span class="w"> </span><span class="n">ratio</span>
<span class="w">         </span><span class="err">│</span><span class="w">   </span><span class="err">→</span><span class="w"> </span><span class="n">DAF</span><span class="mi">-16</span><span class="w"> </span><span class="n">activation</span><span class="w"> </span><span class="o">+</span><span class="w"> </span><span class="n">mTOR</span><span class="w"> </span><span class="n">inhibition</span>
<span class="w">         </span><span class="err">│</span>
<span class="w">         </span><span class="err">└─</span><span class="w"> </span><span class="n">HLH</span><span class="mi">-30</span><span class="w"> </span><span class="p">(</span><span class="n">TFEB</span><span class="w"> </span><span class="n">autophagy</span><span class="w"> </span><span class="n">master</span><span class="p">)</span>
<span class="w">             </span><span class="err">→</span><span class="w"> </span><span class="n">Autophagy</span><span class="w"> </span><span class="n">gene</span><span class="w"> </span><span class="n">activation</span>
<span class="w">             </span><span class="err">→</span><span class="w"> </span><span class="n">Lysosomal</span><span class="w"> </span><span class="n">biogenesis</span>
<span class="w">                 </span><span class="err">↓</span>
<span class="w">         </span><span class="n">Coordinated</span><span class="w"> </span><span class="n">proteostasis</span><span class="w"> </span><span class="n">upregulation</span>
<span class="w">         </span><span class="n">Extended</span><span class="w"> </span><span class="n">lifespan</span>
<span class="w">         </span><span class="n">Enhanced</span><span class="w"> </span><span class="n">stress</span><span class="w"> </span><span class="n">resistance</span>
</code></pre></div>

<h3 id="42-age-dependent-decline-in-proteostasis-capacity">4.2 Age-Dependent Decline in Proteostasis Capacity</h3>
<p>The proteostasis network exhibits <strong>progressive deterioration</strong> with age:</p>
<ol>
<li><strong>HSF-1 activity declines</strong>: Less responsive to heat at reproductive maturity</li>
<li><strong>Aggregate accumulation</strong>: Misfolded proteins increasingly insoluble</li>
<li><strong>Autophagy flux reduced</strong>: Lysosomal clearance becomes rate-limiting</li>
<li><strong>ERAD impairment</strong>: ER stress sensitivity increases</li>
<li><strong>Longevity signal loss</strong>: DAF-16 and HLH-30 less effective with age</li>
</ol>
<h4 id="consequence">Consequence</h4>
<p>Accumulation of protein aggregates and organellar dysfunction → Age-dependent neurodegeneration, vulnerability to aggregation diseases.</p>
<h3 id="43-disease-models-in-c-elegans">4.3 Disease Models in C. elegans</h3>
<p>The proteostasis pathway is conserved, enabling disease modeling:</p>
<h4 id="polyglutamine-expansion-huntingtons">Polyglutamine Expansion (Huntington's)</h4>
<ul>
<li>PolyQ::YFP transgenes form aggregates</li>
<li>HSF-1 activation ameliorates aggregation</li>
<li><a href="../../genes/worm/hsp-16.2/hsp-16.2-ai-review.html">hsp-16.2</a>, hsp-70 extend survival</li>
</ul>
<h4 id="alpha-synuclein-parkinsons">Alpha-Synuclein (Parkinson's)</h4>
<ul>
<li>A53T expression in neurons</li>
<li>Mitophagy (<a href="../../genes/worm/lgg-1/lgg-1-ai-review.html">lgg-1</a>, <a href="../../genes/worm/bec-1/bec-1-ai-review.html">bec-1</a>) essential for clearance</li>
<li>Activation of daf-16, <a href="../../genes/worm/hlh-30/hlh-30-ai-review.html">hlh-30</a> extends life</li>
</ul>
<h4 id="amyloid-beta-alzheimers">Amyloid-Beta (Alzheimer's)</h4>
<ul>
<li>Aβ1-42 expression causes senile plaques</li>
<li>Autophagy enhancement (HLH-30) ameliorates toxicity</li>
<li>Sirtuins (SIR-2.1) provide protection</li>
</ul>
<hr />
<h2 id="part-5-curation-summary-and-quality-assessment">Part 5: Curation Summary and Quality Assessment</h2>
<h3 id="51-annotation-statistics">5.1 Annotation Statistics</h3>
<table>
<thead>
<tr>
<th>Priority</th>
<th>Genes</th>
<th>Annotations</th>
<th>ACCEPT</th>
<th>KEEP_AS_NON_CORE</th>
<th>MODIFY</th>
<th>REMOVE</th>
<th>UNDECIDED</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>1</strong></td>
<td>6</td>
<td>234</td>
<td>173 (74%)</td>
<td>43 (18%)</td>
<td>17 (7%)</td>
<td>0</td>
<td>1 (0.4%)</td>
</tr>
<tr>
<td><strong>2</strong></td>
<td>6</td>
<td>213</td>
<td>155 (73%)</td>
<td>18 (8%)</td>
<td>33 (15%)</td>
<td>1 (0.5%)</td>
<td>6 (3%)</td>
</tr>
<tr>
<td><strong>3</strong></td>
<td>6</td>
<td>421</td>
<td>298 (71%)</td>
<td>81 (19%)</td>
<td>35 (8%)</td>
<td>4 (1%)</td>
<td>3 (1%)</td>
</tr>
<tr>
<td><strong>TOTAL</strong></td>
<td>18</td>
<td>868</td>
<td>626 (72%)</td>
<td>142 (16%)</td>
<td>85 (10%)</td>
<td>5 (0.6%)</td>
<td>10 (1%)</td>
</tr>
</tbody>
</table>
<h3 id="52-key-curation-decisions">5.2 Key Curation Decisions</h3>
<h4 id="systematic-removal-of-vague-protein-binding-terms">Systematic Removal of Vague "Protein Binding" Terms</h4>
<p><strong>Action</strong>: Replace GO:0005515 (uninformative "protein binding") with specific molecular functions</p>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Instances</th>
<th>Replacement Terms</th>
</tr>
</thead>
<tbody>
<tr>
<td><a href="../../genes/worm/hsp-90/hsp-90-ai-review.html">hsp-90</a></td>
<td>10</td>
<td>GO:0051879 (Hsp90 protein binding)</td>
</tr>
<tr>
<td><a href="../../genes/worm/daf-21/daf-21-ai-review.html">daf-21</a></td>
<td>8</td>
<td>GO:0051879 (Hsp90 protein binding)</td>
</tr>
<tr>
<td>cdc-48</td>
<td>4</td>
<td>GO:0031593 (polyubiquitin-dependent binding)</td>
</tr>
<tr>
<td><a href="../../genes/worm/lgg-1/lgg-1-ai-review.html">lgg-1</a></td>
<td>4</td>
<td>GO:0044877 (protein-containing complex binding)</td>
</tr>
</tbody>
</table>
<p><strong>Rationale</strong>: GO best practice requires replacing non-informative parent terms with specific, mechanistically accurate child terms that describe actual molecular function.</p>
<h4 id="removal-of-nomenclature-artifacts">Removal of Nomenclature Artifacts</h4>
<p><strong>Action</strong>: REMOVE GO:0050811 (GABA receptor binding) from <a href="../../genes/worm/lgg-1/lgg-1-ai-review.html">lgg-1</a></p>
<p><strong>Rationale</strong>: LGG-1 name reflects historical discovery of mammalian GABARAP protein through binding to GABA receptors. C. elegans <a href="../../genes/worm/lgg-1/lgg-1-ai-review.html">lgg-1</a> has no GABA receptors (invertebrate nervous system) and no functional evidence for GABA receptor interaction. Annotation perpetuates nomenclature artifact without biological relevance.</p>
<h4 id="mechanical-accuracy-corrections">Mechanical Accuracy Corrections</h4>
<p><strong>Action</strong>: REMOVE GO:0042026 (protein refolding) from <a href="../../genes/worm/hsp-16.2/hsp-16.2-ai-review.html">hsp-16.2</a></p>
<p><strong>Rationale</strong>: Small HSPs are ATP-independent "holdase" chaperones that prevent aggregation but cannot directly refold proteins. ATP-dependent refolding is the exclusive domain of HSP70/HSP90/AAA+ ATPases. The distinction is mechanistically important for understanding proteostasis.</p>
<h4 id="tissue-specific-and-developmental-context">Tissue-Specific and Developmental Context</h4>
<p><strong>Action</strong>: Mark dauer formation, developmental processes as KEEP_AS_NON_CORE in multiple genes</p>
<p><strong>Rationale</strong>: Dauer formation is a developmental phenotype mediated indirectly through core proteostasis functions (e.g., HSP90 stabilizing sensory receptors affects dauer decision). The core function is chaperone activity, not dauer formation per se.</p>
<h3 id="53-evidence-code-assessment">5.3 Evidence Code Assessment</h3>
<h4 id="phylogenetic-inference-iba-high-quality">Phylogenetic Inference (IBA) - High Quality</h4>
<p>C. elegans proteostasis genes show exceptional conservation across eukaryotes, making IBA annotations appropriate and well-supported:</p>
<ul>
<li><strong>HSF-1 domain structure</strong>: Conserved across yeast → mammals</li>
<li><strong>HSP70 catalytic mechanism</strong>: Identical across prokaryotes → eukaryotes</li>
<li><strong>ERAD components</strong>: Same cofactor requirements (CDC-48/UFD-1/NPL-4) in yeast and humans</li>
<li><strong>DAF-16 DNA-binding domain</strong>: Forkhead domain structure conserved across invertebrates and vertebrates</li>
</ul>
<h4 id="experimental-evidence-ida-imp-critical-validation">Experimental Evidence (IDA, IMP) - Critical Validation</h4>
<p>For genes reviewed here, C. elegans provides excellent experimental validation:</p>
<ul>
<li><strong>Microscopy (IDA)</strong>: Transparent body enables live imaging of protein localization</li>
<li><strong>Genetic manipulation (IMP)</strong>: Temperature-sensitive alleles, RNAi knockdowns, CRISPR editing</li>
<li><strong>Biochemistry (IDA, IEA)</strong>: In vitro chaperone assays, binding studies</li>
<li><strong>Genomic analysis (IEA)</strong>: Domain-based functional predictions</li>
</ul>
<h4 id="computedinferred-iea-lower-but-acceptable-confidence">Computed/Inferred (IEA) - Lower but Acceptable Confidence</h4>
<p>Domain-based IEA annotations are appropriate for:</p>
<ul>
<li><strong>ATP binding</strong> (nucleotide binding domain present)</li>
<li><strong>Chaperone complex membership</strong> (protein complex database)</li>
<li><strong>Cellular localization</strong> (prediction algorithms + experimental confirmation)</li>
</ul>
<h3 id="54-cross-project-consistency">5.4 Cross-Project Consistency</h3>
<p>Three genes were reviewed across multiple projects:</p>
<table>
<thead>
<tr>
<th>Gene</th>
<th>Projects</th>
<th>Consistency</th>
</tr>
</thead>
<tbody>
<tr>
<td><strong><a href="../../genes/worm/skn-1/skn-1-ai-review.html">skn-1</a></strong></td>
<td>SURVEILLANCE_IMMUNITY, PROTEOSTASIS</td>
<td>✓ Consistent</td>
</tr>
<tr>
<td><strong><a href="../../genes/worm/hlh-30/hlh-30-ai-review.html">hlh-30</a></strong></td>
<td>SURVEILLANCE_IMMUNITY, MITOPHAGY, PROTEOSTASIS</td>
<td>✓ Consistent</td>
</tr>
<tr>
<td><strong><a href="../../genes/worm/atfs-1/atfs-1-ai-review.html">atfs-1</a></strong></td>
<td>MITOPHAGY, UPR_STRESS, PROTEOSTASIS (not reviewed here)</td>
<td>✓ Consistent</td>
</tr>
</tbody>
</table>
<p>All cross-project reviews show excellent consistency in core functional annotations, validating the systematic curation approach.</p>
<hr />
<h2 id="part-6-therapeutic-implications-and-future-directions">Part 6: Therapeutic Implications and Future Directions</h2>
<h3 id="61-therapeutic-targets-by-disease">6.1 Therapeutic Targets by Disease</h3>
<h4 id="neurodegeneration-alzheimers-parkinsons-huntingtons-als">Neurodegeneration (Alzheimer's, Parkinson's, Huntington's, ALS)</h4>
<p><strong>Target</strong>: Enhance HSF-1 activity or bypass decline</p>
<ul>
<li><strong>HSP70/HSP90 upregulation</strong>: Pharmacological (geldanamycin analogues)</li>
<li><strong>TFEB activation (HLH-30)</strong>: Enhance autophagy-lysosomal clearance</li>
<li><strong>DAF-16 activation</strong>: Extend proteostasis capacity via longevity pathway</li>
<li><strong>SIR-2.1 activation</strong>: NAD+ precursors (NMN, NR) enhance sirtuin function</li>
</ul>
<h4 id="cancer">Cancer</h4>
<p><strong>Target</strong>: Exploit proteostasis addiction</p>
<ul>
<li><strong>HSP90 inhibition</strong>: Broad-spectrum kinase inhibitor; clients required for oncogenic signaling</li>
<li><strong>Proteasome inhibition</strong>: Carfilzomib, bortezomib approved for multiple myeloma</li>
<li><strong>Autophagy inhibition</strong>: Complementary to proteasome inhibitors in certain contexts</li>
</ul>
<h4 id="metabolic-disease-diabetes-obesity">Metabolic Disease (Diabetes, Obesity)</h4>
<p><strong>Target</strong>: Enhance DAF-16/AAK-2 signaling</p>
<ul>
<li><strong>AMPK activators</strong>: Metformin, AICAR, natural products (resveratrol)</li>
<li><strong>mTOR inhibitors</strong>: Rapamycin extends lifespan in model organisms</li>
<li><strong>Sirtuin activators</strong>: NAD+ boosters enhance SIR-2.1 activity</li>
<li><strong>Caloric mimetics</strong>: Drugs that activate longevity pathways without actual fasting</li>
</ul>
<h4 id="aging-and-age-associated-disease">Aging and Age-Associated Disease</h4>
<p><strong>Target</strong>: Restore proteostasis capacity decline</p>
<ul>
<li><strong>Heat shock response enhancement</strong>: Small molecules reactivating HSF-1</li>
<li><strong>Autophagy induction</strong>: mTOR inhibition, TFEB activation</li>
<li><strong>NAD+ restoration</strong>: Age-related NAD+ decline reversal</li>
<li><strong>Mitochondrial quality control</strong>: Enhanced mitophagy via BEC-1/LGG-1</li>
</ul>
<h3 id="62-model-organism-validation">6.2 Model Organism Validation</h3>
<p>The C. elegans proteostasis pathway has already validated numerous targets:</p>
<ol>
<li><strong>HSP70/HSP90 in aggregation diseases</strong>: Validated lifespan extension with heat shock protein upregulation</li>
<li><strong>Autophagy enhancement in neurodegeneration</strong>: HLH-30 activation ameliorates polyQ toxicity</li>
<li><strong>Longevity pathway activation</strong>: DAF-16 activation extends lifespan up to 5-fold in <a href="../../genes/worm/daf-2/daf-2-ai-review.html">daf-2</a> mutants</li>
<li><strong>Sirtuin-mediated protection</strong>: SIR-2.1 essential for caloric restriction lifespan extension</li>
</ol>
<h3 id="63-future-research-directions">6.3 Future Research Directions</h3>
<h4 id="age-dependent-network-changes">Age-Dependent Network Changes</h4>
<ul>
<li>How does HSF-1 activity decline mechanistically?</li>
<li>What triggers age-dependent autophagy decline?</li>
<li>How can aging-associated changes be reversed?</li>
</ul>
<h4 id="tissue-autonomous-vs-non-autonomous-proteostasis">Tissue-Autonomous vs. Non-Autonomous Proteostasis</h4>
<ul>
<li>Neuronal regulation of systemic proteostasis (transcellular signaling)</li>
<li>Aging-associated loss of tissue-tissue communication</li>
<li>Restoration of non-autonomous signaling in aged animals</li>
</ul>
<h4 id="integration-with-other-cellular-quality-control-systems">Integration with Other Cellular Quality Control Systems</h4>
<ul>
<li>Proteostasis × Mitochondrial quality control (mitophagy role)</li>
<li>Proteostasis × ER quality control (ERAD, UPR-ER)</li>
<li>Proteostasis × Genomic stability (CDC-48 in replication)</li>
<li>Proteostasis × Immune response (HLH-30, SKN-1 in immunity)</li>
</ul>
<h4 id="disease-specific-proteostasis-defects">Disease-Specific Proteostasis Defects</h4>
<ul>
<li>Why does proteostasis capacity affect specific neuron types differently?</li>
<li>How do different aggregation-prone proteins (tau, α-syn, Aβ) affect distinct pathway components?</li>
<li>Can pathway component replacement restore lost capacity?</li>
</ul>
<hr />
<h2 id="conclusion">Conclusion</h2>
<p>The C. elegans proteostasis pathway represents a conserved and hierarchical system for maintaining protein homeostasis:</p>
<ol>
<li><strong>Rapid response layer</strong> (HSR): Heat shock response provides immediate stress buffering</li>
<li><strong>Sustained clearance layer</strong> (UPS/autophagy): Remove accumulated misfolded proteins</li>
<li><strong>Adaptive longevity layer</strong> (DAF-16/HLH-30): Extend proteostasis capacity under stress</li>
</ol>
<p>With <strong>18 genes, 868 GO annotations</strong>, and comprehensive literature integration, this pathway review provides a foundation for:</p>
<ul>
<li><strong>Mechanistic understanding</strong> of how proteostasis declines with age</li>
<li><strong>Disease modeling</strong> of aggregation diseases in C. elegans</li>
<li><strong>Drug target identification</strong> at every step of the pathway</li>
<li><strong>Therapeutic validation</strong> before translation to mammalian systems</li>
</ul>
<p>The systematic curation demonstrates that <strong>high-quality GO annotations</strong> are essential for capturing the nuanced relationships between gene function, cellular stress responses, developmental processes, and organismal aging.</p>
<hr />
<h2 id="references">References</h2>
<p>[Compiled from all Priority 1, 2, and 3 gene reviews with &gt;100 primary literature citations]</p>
<p><strong>Key Representative References</strong>:</p>
<ul>
<li>Morimoto RI (2020) "The heat shock response: Systems biology of proteotoxic stress in aging and disease" Cold Spring Harb Perspect Biol 12:a034267</li>
<li>Ben-Zvi A et al. (2009) "Genetic and pharmacological suppression of aggregate-induced proteotoxicity in C. elegans" PNAS 106:5909-5914</li>
<li>Prahlad V et al. (2008) "Nonautonomous control of C. elegans behavior and stress response by the nervous system" PNAS 105:20994-20999</li>
<li>Nollen EA et al. (2004) "Protective role of the C. elegans Heat shock factor HSF-1" PNAS 101:12380-12385</li>
<li>Labbadia J &amp; Morimoto RI (2015) "The biology of proteostasis in aging and disease" Annu Rev Biochem 84:435-464</li>
</ul>
<hr />
<p><strong>Project Completion Date</strong>: 2025-12-30<br />
<strong>Total Genes Reviewed</strong>: 18<br />
<strong>Total Annotations</strong>: 868<br />
<strong>Project Status</strong>: ✅ COMPLETE</p>
    </div>

    <footer>
        <small>Generated from CAEEL_PROTEOSTASIS-pathway.md</small>
        <small>AI Gene Review Project</small>
    </footer>
</body>
</html>